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ABSTRACT
The outer surface lipoprotein (osp) layer forms an interface between the internal and the external
environment of the Lyme disease spirochete, Borrelia burgdorferi. The homeostatic maintenance of the
osp layer effectuates adaptation of B. burgdorferi as it gets transmitted from the tick vector to a mammalian
host and vice-versa. However, the regulation of the outer surface lipoproteins (osps) is still a conundrum
for borrelia scientists. Part of this dissertation inquires about the homeostatic maintenance of the osp layer.
We found that the deletion of the dominantly expressed tick phase osp, OspA, induces expression of two
other osps. OspD, and BBJ41. Also, increased expression of OspC was seen in borrelia mutants lacking
OspA, OspD, and BBJ41. These results suggest constant osp layer maintenance, irrespective of the presence
or the absence of the dominant Osps, like OspA and OspC. Furthermore, our conclusive electron
microscopic study demonstrates that the overall density of the osp layer remains identical in wild type and
mutant B. burgdorferi, lacking either several osps or the dominantly expressed OspA.
OspA is abundantly expressed on the borrelial surface as it persists in an unfed tick. A blood meal causes
rapid downregulation of OspA as B.burgdorferi prepares to infect the mammalian host. The downregulation
of OspA is speculated to be regulated by an unknown repressor protein. The remaining part of this
dissertation pertains to the investigation of this unknown repressor protein for ospA. The borrelia oxidative
stress regulator protein, BosR, has been attributed with an indirect role in OspA downregulation. However,
due to its homolgy with a family of transcriptional repressors, BosR is more likely to cause direct repression
of OspA. Therefore, we investigated the direct interaction of BosR and the ospA regulatory region. The
DNA binding experiments demonstrated that borrelia oxidative stress regulator, BosR, binds directly to the
cisI and cisII regulatory regions of ospA promoter. Thus, conclusively, BosR acts as a repressor protein
which causes OspA downregulation in B. burgdorferi.

x

CHAPTER 1
BACKGROUND AND OBJECTIVES
Literature review
The Lyme disease agent, Borrelia burgdorferi is a microaerophilic, gram negative motile
bacteria, which belongs to an ancient phylum: spirochaetes, genus: Borrelia, class: Spirochaetes,
order: Spirochaetales, and family: Spirochaetaceae (Paster and Dewhirst 2000, Brisson et al.
2012).
The term spirochete emanates from the helical/serpentine morpholgy of the bacteria. In nature
the spirochetes may be free dwelling or exist within a host, a very few spirochetes act as a
pathogen (Paster and Dewhirst 2000). Borrelia burgdorferi is one of the pathogenic genus under
spirochetes causing tick borne disease called the Lyme disease (Paster and Dewhirst 2000).
In 1982, the first isolate of Borrelia burgdorferi was obtained (Burgdorfer et al. 1982). Since
then many borrelia isolates have been obtained throughout the world. The genetic analysis of the
different isolates have resulted in formation of the Borrelia burgdorferi sensu lato complex. This
complex includes up to 18 Borrelia species (Stanek and Reiter 2011), only three of these are
known to be true human pathogens, namely: B. burgdorferi sensu stricto, B. garinii, and B.
afzelii. While B. garinii and B. afzelii are predominant Lyme disease agents in Europe, B.
burgdorferi sensu stricto causes Lyme disease in the North America (Baranton et al. 1992).
Figure 1.1 taken from (Steere, Coburn, and Glickstein 2004) below shows distribution of other
borrelia isolates.
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Figure 1.1. Genospecies of Borrelia burgdorferi and their tick vectors and location: Taken from
(Steere, Coburn, and Glickstein 2004) depicts worldwide distribution of several members of
Borrelia burgdorferi sensu lato complex along with principal tick vectors and location

Lyme disease recognition in the United States
The first Lyme disease cases were reported in the form of juvenile rheumatoid arthritis amongst
a group of children from Lyme village, Connecticut in year 1976 (Steere et al. 1977, Steere
1989). In the years that followed, the doctors and scientists proved that Lyme disease was
transmitted by bite from an infected Ixodes tick (Steere 1989) and caused by a spirochete called
Borrelia burgdorferi (Burgdorfer et al. 1982, Steere 1989).
Even after three decades of its discovery, today Lyme disease stands as most commonly reported
vector borne disease (Steere 2006). According to CDC “Lyme disease is the most commonly
reported vector borne illness in the United States in 2012, it was the 7th most common
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Nationally Notifiable disease” (http://www.cdc.gov/lyme/stats/index.html). As shown in figure
1.2 Lyme disease continues its trend of newly reported cases in past 10 years, no significant
control of the disease has been achieved.

Figure 1.2. Reported cases of Lyme disease by year, United States, 2003-2012:
(Centers for Disease Control and Prevention National Center for Emerging and Zoonotic
Infectious Diseases Division of Vector-Borne Diseases, last reviewed September, 2013)
http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html.
The number of confirmed cases ranged from a low of 19,804 in 2004 to high of 29,959 in 2009.
*National Surveillance case definition revised in 2008 to include probable cases;
(detail:http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/lyme_disease_2008.htm)

The comparison of reported cases in figure 1.4 and figure 1.5 show visible increase in
distribution of the reported cases since year 2001 to 2012, the total number of cases reported in
the years 2001- 2011 varied from 17029 - 24364, (Centers for Disease Control and Prevention,
revised september,2012, http://www.cdc.gov/lyme/stats/maps/interactiveMaps.html).
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Figure 1.3. Map showing Lyme disease reported case distribution in year 2001 (Centers for
Disease Control and Prevention, http://www.cdc.gov/lyme/stats/maps/interactiveMaps.html )

Figure 1.4. Map showing Lyme disease reported case distribution in year 2012 (Centers for
Disease Control and Prevention, http://www.cdc.gov/lyme/stats/maps/map2012.html)
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Clinical symptoms
In order to transmit the Lyme borrelia and initiate appearance of the cutaneous manifestation, the
Ixodes tick needs to complete at least 36-48 hours on its host (Peavey and Lane 1995). One of
the studies indicated even lower tick attachment time (24hrs) may be required in order to
transmit Lyme borrelia (Piesman et al. 1987). While up to 90% people show erythema migrans at
the site of tick bite (Gerber et al. 1996) (Krause et al. 1996), more than half of the infected
people fail to detect or recall the tick bite, also the nymph stage of tick is hard to see and be
recognized (Asbrink and Hovmark 1988). The lesion of erythema migrans initiates as a small red
macule from the tick bite site and within a week of bite, migrates outwardly leading to formation
of typical “Bull’s eye rash” figure1.6 (Nadelman et al. 1996). However, erythema migrans
cannot be considered as a diagnostic lesion for Lyme disease (Asbrink and Hovmark 1988), as
some times rash may lack the central clearance, appear similar to other tick bites (Kirkland et al.
1997), or appear as a migrating lesion away from the unnoticed initial tick bite site (Nadelman et
al. 1996).

Figure 1.5. Erythema migrans leision with central clearing (bull’s eye rash): Picture from Centre
for Disease Control and Prevention webpage, last revised on April, 2013
(http://www.cdc.gov/lyme/signs_symptoms/index.html)
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Early classification for clinical symptoms of Lyme disease was given by Steere et al. in 1983.
Under this classification the course of Lyme disease was divided into three stages: Stage one of
Erythema migrans, stage two including meningitis or Bell's palsy, and stage three showing
arthritis. As there was overlap of symptoms under different stages of above early classification
the clinical manifestations of Lyme disease was reclassified by Asbrink & Hovmark in 1988.
The new classification was based on classification for Syphilis caused by spirochete called
Treponema pallidum. Under this classification, clinical manifestation for Lyme disease has been
divided into three broad stages (Nadelman and Wormser 1998, Steere 1989, Yoshinari, Steere,
and Cossermelli 1989):
1. Stage one: The early localized stage (Asbrink and Hovmark 1988), occurs within 3-30 days of
the infectious Ixodes tick bite. Main symptoms seen are erythema migrans, malaise, headache,
fever, myalgia, and fever (viral fever like signs) (Steere et al. 1983).
2. Stage two: The early disseminated stage (Asbrink and Hovmark 1988), ensues within days to
weeks. This stage is characterized by borrelia lymphocytoma, meningo-polyneuritis, and
multiple systemic effects like: Atrioventricular block (Steere et al. 1980), multiple erythema
migrans, myalgia, arthralgia, facial or Bell's palsy (loss of muscle tone on one or both sides of
the face, figure 1.6), and severe headaches and neck stiffness due to meningitis (inflammation of
the spinal cord).(Ho, Melanson, and Desai 2012)
3. Stage three: The late stage (Asbrink and Hovmark 1988) or stage of persistent infection,
known to occur months to years of initial tick bite. This stage includes acrodermatitis chronica
atrophicans, monoarticular or oligoarticular arthritis, figure 1.7 (Steere et al. 1977) or chronic
neurologic manifestations like encephalomyelytis and peripheral neuropathy. (Steere 2001)
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Figure 1.6. Loss of facial muscle tone on one or both sides: Bell’s palsy. Can be seen in early
disseminated stage (picture from Centre for Disease Control and Prevention, CDC- Division of
Vector-borne Infectious Diseases http://www.cdc.gov/lyme/signs_symptoms/index.html).

Figure 1.7. Lyme arthritis, painful swelling of either single or both knee joints can ensue in late
disseminated stage. Picture from CDC- Division of Vector-borne Infectious Diseases

Diagnosis of Lyme disease
In endemic regions , the clinical signs like erythema migrans (Bull’s eye rash ) have preliminary
diagnostic value, however, the culturing of Borrelia burgdorferi from these leisions enables
definitive diagnosis (Tugwell et al. 1997). The diagnostic cultures can be obtained from
erythema migrans, acrodermatitis, and occasionally from plasma and cerebrospinal fluid
samples. However, the patients in late stage of the disease may be diagnosed based on
Polymerase Chain Reaction (PCR) for detection of borrelia in joint fluid (Nocton et al. 1994). In
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suspected cases for extra cutaneous Lyme disease tissues having borrelia may be inaccessible for
culturing and hence serum based diagnosis is of greater value, these tests include Enzyme Linked
Immunosorbent

Assay

(ELISA),

immunoblot

or

western

blot

test,

and

indirect

immunofluorescence assay (Lebech 2002, Tugwell et al. 1997).
The Center for Disease Control and Prevention has recommended two step (Figure 1.8) diagnosis
of Lyme disease using blood sample for detection of antibodies against Borrelia burgdorferi.
Under the first step testing, either the Enzyme Immunoassay (EIA) or the Immunofluorescence
Assay (IFA) test is performed. If the first test is negative then no further test is conducted. In
case of an indeterminate or positive result, second test, the Western blot or immunoblot is
performed. If both the tests are positive only then the sample is considered true positive.
However, serum based tests are not considered reliable by many scientists working with the
Lyme disease (Steere et al. 1993, Hofmann 1996), as antibodies may be absent in patients with
early disease symptoms, while, antibodies may persist even after years after clinical recovery
(Gajovic et al. 2010), further patients treated do not show presence of antibodies. Due to
shortcomings in serum based diagnosis a recent improved ELISA test has been recommended ,
in this test recombinant chimeric Borrelia burgdorferi proteins are used for detection (GomesSolecki et al. 2000).
The search and standardization for an adequate diagnosis for Lyme disease continues and
someday CDC two tier test recommendation may be changed, covering for distinct Lyme disease
diagnostic requirements (Aguero-Rosenfeld et al. 2005, Wormser et al. 2013). But at this time
the following Two–Tier decision system (Figure 1.8) recommended by CDC continues as
diagnostic guide tool.
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Figure 1.8. Two-tier testing decision Tree from Centre for Disease Control and Prevention
(http://www.cdc.gov/lyme/diagnosistesting/LabTest/TwoStep/index.html)

Treatment of Lyme disease
In the early Lyme disease stage the serum testing is of limited utility , as there is no IgG in
circulation during first 14 days of infection (Dressler et al. 1993). If an engorged Ixodes nymphal
tick is found attached then a single 200mg dose of doxycycline is curative (Nadelman et al.
2001). In apparent erythema migrans the antibiotic treatment is continued for 10-20 days using
doxycycline, both in adults and children above 8 years of age. Amoxicillin is considered best
choice in children younger than 8 years (Wormser et al. 2003). The patients treated with
antibiotics during the initial phase of the disease tend to have reinfection with Lyme disease
(Bennet and Berglund 2002). Intravenous clindamycin, oral atovaquone, or oral quinine, and
azithromycin is considered effective in people having coinfection with other vector-borne agents
like Babesia or Anaplasma (Brown et al. 1995). In neurologic symptoms of Lyme disease,
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intravenous antibiotic therapy with ceftriaxone is considered effective (Oschmann et al. 1998).
Lyme arthritis can be treated with oral antibiotics doxycycline or amoxicillin, however treated
patients can still develop either neuronal Lyme disease, or persistent arthritis with no effect of
antibiotics (Steere et al. 1994).
Lyme disease transmission
Lyme disease is a zoonotic disease transmitted amongst ticks of Ixodes ricinus complex and a
mammalian host (Anderson 1989). Borrelia burgdorferi infects the mammalian host as the
Ixodes tick vector takes up the blood meal (Steere, Broderick, and Malawista 1978, Wallis et al.
1978). Though Lyme disease is considered as a zoonosis, humans are incidental hosts and once
infected act as dead end host (Baum 2008).
The first B. burgdorferi isolate was found in an ixodid tick from Shelter island at New York in
1981 (Burgdorfer, Barbour et al. 1982). The ixodes ticks thrive well in the temperate climate of
the northern hemisphere, this is also true for Borrelia burgdorferi surviving amongst various
mammalian reservoir hosts (Radolf et al. 2012). The distribution of ticks vary with geographical
location and climatic conditions, while Ixodes scapularis is main vector for northeastern and
upper mid-western United States, Ixodes pacificus is common in the far western United States,
Ixodes persulcatus is found in Asia and Ixodes ricinus in Eurasia (Lane, Piesman, and
Burgdorfer 1991).The change in land use patterns in the late 20th century, particularly the
deforestation followed by reforestation in northeastern and mid-western parts of United States
has provided optimum conditions for Lyme disease vector to propagate (Barbour 1998, Chen et
al. 2005).
Ixodes scapularis, commonly known as the black legged tick was first described in 1979 by
Spielman et al. (Spielman et al. 1979). The different life stages of I. scapularis, include eggs,
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larvae, nymphs, and dimorphic adults (Figure 1.10). The detailed two year life cycle for Lyme
disease vector has been shown in figure 1.9. The trans-stadial transmission of Borrelia
burgdorferi from larval stage to nymphal stage and a blood meal at each developmental stage,
on same reservoir host species ensure the horizontal transmission of infection from infected to
uninfected developmental stage (Burgdorfer 1984b, Drouin, Glickstein, and Steere 2004, Levine,
Wilson, and Spielman 1985).
The questing activity of nymphs coincides with the high outdoor human activities, further the
small size of nymphs help them attach undetected, due to these advantages, the tick vector
nymphs are critical to cause high incidence of Lyme disease in humans, especially during late
spring and early summer (Lane, Piesman, and Burgdorfer 1991).
The developmental stages of tick vector have a broad host range including small mammals and
birds (Anderson 1989, 1988). In its current cycle within the north eastern United States,
Peromyscus leucopus (the white footed mouse) acts as the main reservoir host for the nymphal
and larval stages of ticks (Anderson and Magnarelli 1980, Anderson et al. 1985). The adult ticks
are known to feed on larger animals especially white tailed deer (Odocoileus virginianus)
(Bosler et al. 1984, Carey, Krinsky, and Main 1980, Spielman et al. 1979).
Adaptation of Borrelia burgdorferi
In an unfed tick vector B. burgdorferi (Figure 1.11) remains dormant within the midgut. In
response to blood meal the spirochetes move from hemocoel to the salivary gland (Ribeiro et al.
1987). It is during the blood meal that borrelia infects the mammalian host through tick saliva
(Burgdorfer 1984a, Schwan and Piesman 2000). During its journey from tick midgut to the
mammalian host environment B. burgdorferi undergoes several adaptive changes (Schwan and
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Piesman 2000, Schwan et al. 1995). Most eminent of these adaptations is the rapid change in the
outer surface lipoprotein expression (Schwan and Piesman 2000, Schwan et al. 1995).

Figure 1.9. Two year cycle of Lyme disease vector: at least one blood meal is taken at every
stage, the adult female tick lay eggs in the spring after feeding on a large mammalian host, in
summer eggs hatch to larvae which feed on small mammals and birds and molt into nymphs
during next spring, these nymphs again feed on a mammalian host during late spring or early
summer and molt into adults the following fall. It is during the nymph feeding season that
humans become incidental host as the peak outdoor activities coincide with the questing nymphs.
CDC- Division of Vector-borne Infectious Diseases, last modified Nov 15, 2011.
(http://www.cdc.gov/lyme/transmission/blacklegged.html)
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Figure 1.10. Comparative morphology of the different life stages of the Lyme disease vector
Ixodes Scapularis (CDC- Division of Vector-borne Infectious Diseases, last modified January
11, 2013, http://www.cdc.gov/lyme/transmission/index.html)

A

B

Figure1.11. Morphology of Borrelia burgdorferi (A) Shows spiral morphology of Borrelia
burgdorferi.(Rosa, Tilly, and Stewart 2005) Borreliae are 10-30µm long and .2-.3µm wide and
have 7-11 periplasmic flagella imparting spiral shape (Burgdorfer et al. 1982) (B) “Schematic
representation of a spirochete” from (Canale-Parola 1977) shows outer envelope in broken line ,
protoplasmic cylinder in solid line which follows along outer envelope, and thin solid line
indicates the axial fibrils.

Unlike other double membraned gram negative bacteria, that express lipopolysaccharide on their
outer-membrane, borrelia express proteins covalently linked to lipids known as outer surface
lipoproteins (osps) (Barbour and Hayes 1986, Bergstrom, Bundoc, and Barbour 1989, Brandt et
al. 1990). The outer surface lipoproteins form an interface between borrelia’s internal and
external environment (Figure1.12).
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Figure1.12. Comparative membrane structures of Gram-positive, Gram-negative and B.
burgdorferi. The outer membrane of borrelia is markedly distinct from Gram-positive and other
Gram-negative bacteria. The borrelial outer membrane is fluid, fragile, and lacks
Lipopolysaccharide, instead it is adorned with several lipoproteins anchored to the outer
membrane by process called lipidation.

As the external environment alternates from tick midgut to mammalian host, the osps play
critical role in survival of borrelia (Brandt et al. 1990, Bergstrom, Bundoc, and Barbour 1989).
As shown in figure 1.13, in an unfed tick, Borrelia burgdorferi remains low in number and
expresses outer surface protein A (OspA) as the major surface lipoprotein (Fingerle et al. 1995).
In response to the blood meal there is rapid multiplication of borrelia, along with increase in
number there is rapid downregulation of OspA (Schwan et al. 1995). As the borrelia migrates
from hemocoel to the tick salivary gland it expresses Outer surface protein C as major surface
protein (De Silva and Fikrig 1997b). This reciprocal expression of OspA and OspC enables the
mobilization of borrelia from the tick midgut to the salivary gland, and finally into the
mammalian host (Schwan et al. 1995, de Silva and Fikrig 1997a).
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Viability determination of B. burgdorferi
The Lyme disease agent, B. burgdorferi can be cultured readily from the EM skin lesions
(Berger et al. 1992, Mitchell et al. 1993) and often from the concomitant blood samples in BSKH medium, thus indicating the presence of viable organisms in the specimen.
One of the most commonly used methods for differentiating alive and dead spirochetes is
enumeration of the motile spirochetes in culture medium inoculated with the infected specimen
under the dark field microscope. The spirochetes which lie still under the dark field microscope
are considered dead and not taken into account while enumeration.
The culture based classical methods for detecting the spirochete viability and enumerations have
limited sensitivity, and are time consuming. Several molecular methods targeting DNA and RNA
have also been developed for the detection of total as well as viable spirochetes offering higher
speed, sensitivity, and specificity. However, most attempts to culture the causative organism
form low burden sites such as synovial fluid (SF) have been negative (Steere et al. 1984,
Bradley, Johnson, and Goodman 1994) in contrast, Polymerase Chain Reaction (PCR) results are
often positive at these sites. The presence of viable spirochetes have been quantified by real-time
PCR and confirmed by in-vitro culture after 7 months of infection and up to four weeks after
completion of penicillin treatment (Pahl et al. 1999). PCR targeting spirochete DNA have been
reported to present some discrepancy with culture results, which could be because of the very
low spirochete load or the organisms are injured, or dead. Therefore, detection of B. burgdorferi
DNA may not be a reliable test of active joint infection in Lyme disease. Quantification of B.
burgdorferi messenger RNA (mRNA), and ribosomal RNA (rRNA) has been a reliable tool for
differentiation and enumeration of viable spirochetes form the total load identified by DNA
based assays. Quantitative PCR and RT-PCR based assays are being increasingly used in Lyme
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disease patients for determination of active infection in patients with persistent arthritis after
antibiotic therapy.

Figure 1.13. OspA and OspC crossregulation during the infectious cylce of B. burgdorferi. OspA
is abundantly expressed in tick vector and is rapidly downregulated in response to blood meal in
order to evade immune detection. OspC expression is increased as B. burgdorferi prepares to
infect a mammalian host. Figure from (Mulay et al. 2009)

Animal model of Lyme disease
In general, the animal model for Lyme disease should display disease pathology similar to that of
human patients. Thus the animals which can be infected with the Lyme disease agent in
laboratory and show persistent infection with B. burgdorferi along with one or more arthritic
joints, and involvement of multiple organs with disease symptoms in heart, joint, and skin can be
considered as the Lyme disease animal model.
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The first animal model for Lyme disease was introduced by Schaible et al. in 1989 as they found
inbred mouse strains (C57BL/6 and BALB/c) inoculated with live B. burgdorferi B31 show
antigen specific T-cell response similar to pathomorphology seen in Lyme disease patients
(Schaible et al. 1989). Same group also showed that the mice having severe combined
immundeficiency syndrome (SCID), thus lacking or having abnormal B-cell and T-cell function,
show progressive polyarthritis and carditis and hence serve even more useful model then
immunocompetent mice strains for studying Lyme disease (Schaible et al. 1990).
In addition to mice, many other animal species were proved to be useful in studying Lyme
disease. In the year 1984, Kornblatt et al. showed that rabbits could contract Lyme disease
experimentally and show initial signs similar to that in humans (Kornblatt, Steere, and
Brownstein 1984). The same group showed that dogs can show Lyme arthritis similar to humans
(Kornblatt, Urband, and Steere 1985). Mursic et al. found that gerbils show multiorgan
involvement in response to experimental inoculation of B. burgdorferi, and hence can serve as
suitable Lyme disease model to study the pathogenesis and the extent of organ damage (Preac
Mursic et al. 1990). Furthermore, guinea pig was also found to be useful as a animal model for
Lyme disease as it showed Lyme disease symptoms upon inoculation (Sonnesyn et al. 1993).
While most of the rodent and lagomorphs showed Lyme disease infection, none of the animals
mentioned above show central nervous system (CNS) signs of Lyme disease. Rhesus monkeys
are the only experimental animals that could develop neuroborreliosis and hence serve as another
unique Lyme disease animal model (Philipp and Johnson 1994).
Furthermore, the animals which show infection upon laboratory inoculation, can also be used for
cultivation of the pathogen in the mammalian host adapted form. The term host adapted form
represents the antigenic and structural changes taken up by the spirochetes as they transgress
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from ticks to the mammalian host. The isolated borreliae from infected tissue samples undergo
changes in antigenic expression as they multiply and adapt to the laboratory culture conditions.
Thus in order to enable study of spirochetes in the mammalian host adapted form it was essential
to develop a new animal model which could provide mammalian stimuli and allow pathogen to
grow in host adapted stage. Such a novel model was developed by Akins et al. in year 1998, this
model involved implantation of lyme disease spirochetes enclosed within the dialysis membrane
chambers (DMCs) into the peritoneal cavities of sprague dawley rats (Akins et al. 1998). This
model provided researchers with an opportunity to cultivate sufficient amount of the mammalian
host adapted Lyme disease spirochetes for the laboratory experimental analysis. Another added
advantage of this model was possible cultivation of noninfectious borrelia mutant variants in the
mammalian host environment, as DMC protects spirochetes from the host immune system. The
spirochetes in DMC adapt in response to the physiological stimuli provided in the peritoneum of
rats and express virulence determinants which are essential for the disease pathogenesis (Akins
et al. 1998). The detailed use and procedure for the DMC technique has been provided in the
materials and methods section of chapter 2. Hence, the role of Lyme disease animal model is
extended from serving as a disease simulator to cultivator of B. burgdorferi in host adapted form.
Molecular regulation of osp in Borrelia burgdorferi
The deliberate expression and repression of osps in B. burgdorferi is enabled by an intricate
molecular regulatory system. Though the genome of B. burgdorferi has been sequenced
completely by Fraser et al. in 1997, the underlying molecular regulation pathways for
coordinated osp expression is still not completely understood. B. burgdorferi has unique genomic
features (Figure1.14), including a linear chromosome of about one megabasepair, 12 linear and 9
circular plasmids, and each plasmid exists as a single copy per chromosome (Fraser et al. 1997,
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Casjens 2000, Stewart et al. 2005). While there are no genes for cellular biosynthetic reactions in
borrelial genome, the function of a large number of predicted coding sequence is yet to be
understood (Casjens 2000). The outer surface proteins are encoded in the borrelial plasmids, thus
the plasmids basically carry virulence related genes in B. burgdorferi (Stewart et al. 2005).
The molecular regulatory machinery in borrelia differs considerably from other bacteria, as very
few homologous regulatory proteins are present (Samuels 2011). B. burgdorferi has three RNA
polymerase sigma factors: RpoD, RpoN, and RpoS. While RpoD is a major sigma factor,
regulating most of the house keeping genes, RpoN and RpoS are two alternate sigma factors.
RpoN and RpoS form a regulatory pathway in which transcription of rpoS is controlled by RpoN
(Ouyang, Blevins, and Norgard 2008). RpoN binds to the consensus promoter region of rpoS and
enables further RpoS regulated gene expression (Ouyang, Blevins, and Norgard 2008). The
RpoN mediated rpoS expression has been found to be dependent on enhancer binding protein
and two component regulatory system response regulator: Rrp2 (Ouyang, Blevins, and Norgard
2008). Thus the RpoN-RpoS pathway can be called Rrp2-RpoN-RpoS pathway. Further studies
found that Rrp2 is activated by acetyl phosphate a phosphate donor (Xu et al. 2010).
The RpoN-RpoS regulatory pathway has been found to up-regulate several virulence factors,
most of these are essential for borrelial adaptation within the mammalian host (Yang et al. 2005).
The known RpoS regulated crucial virulence factors include outer surface lipoproteins: OspC,
Decorin binding protein A (DbpA) and Decorin binding protein B (DbpB) (Yang et al. 2005).
The rpoS mutant fails to downregulate OspA in the mammalian host like conditions. Hence,
RpoS is essential to cause repression of OspA in mammalian host (Caimano et al. 2005).
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Figure 1.14. Segmented Genome of B. burgdorferi carries numerous plasmids, more than
reported for any other bacteria. The borrelia plasmids are both linear (lp) and circular (cp),
named according to their approximate size in kilobase pairs. Above picture was adapted from a
review by Patricia A.Rosa (Stewart et al. 2005). B. burgdorferi B31 strain is known to carry 2223 plasmids (Stewart et al. 2005, Fraser et al. 1997, Hinnebusch and Barbour 1992). The
plasmids depicted in red required either for maintaining infectivity or persistence of B.
burgdorferi in tick vector.

Unlike other bacteria, RpoS in B. burgdorferi is critical for expression of virulence genes rather
than only in general stress response (Caimano et al. 2007). Also, B. burgdorferi lacking rpoS fail
to produce infection in mouse (Xu et al. 2012). Once the tick vector takes up blood meal, RpoS
is generated and is continuously expressed throughout the borrelial adaptation within the
mammalian host (Banik et al. 2011). Thus in conclusion, RpoS is required by borrelia for
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initiating and maintaining infection in the mammalian host (Banik et al. 2011). However, recent
studies by contemporary research groups have found another regulator called BosR, required for
transcription of rpoS B. burgdorferi (Ohnishi, Piesman, and de Silva 2001, Hyde et al. 2009,
Ouyang et al. 2009).
Due to its preconcieved role in oxidative stress response, the borrelial protein called BB0647 was
renamed as B. burgdorferi oxidative stress regulator or BosR (Hyde et al. 2009). However, the
role of BosR as a borrelial oxidative stress response protein has not been established yet. BosR
mutant successfully colonize the tick vector but fails to establish infection in lab mice. Therefore,
BosR is considered essential for causing infection in a mammalian host (Hyde et al. 2009). BosR
is regarded as the master regulator of RpoN-RpoS regulatory pathway acting like a DNA binding
protein which binds directly on the rpoS gene (Samuels and Radolf 2009, Ouyang, Deka, and
Norgard 2011). Thus, BosR acts as a positive transcription activator and plays additional
regulatory role (Ouyang, Deka, and Norgard 2011).
Our study shows that bosR mutants fail to repress OspA and OspD in mammalian host
environment. OspA and OspD both are outer surface lipoproteins in borrelia primarily expressed
within the tick vector and not required for the infection in the mammalian host (Yang, Pal et al.
2004, Xin Li et al 2007). Though RpoD is known to regulate expression of ospA within the tick
vector, the mechanism causing its repression in response to blood meal is still not known. Thus
the major regulatory role of BosR within the mammalian host is undisputed but remains
unknown (Samuels and Radolf 2009, Ouyang, Deka, and Norgard 2011, Samuels 2011).
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Statement of the problem
Lyme disease still remains the most commonly reported vector born disease in USA. Even
though the genome of Borrelia burgdorferi has been completely sequenced (Fraser et al. 1997),
successful strategies to check the transmission are yet to be developed.
The knowledge accumulated since discovery of Lyme disease is enough to yield a cohesive
picture of cellular and molecular events within the enzootic cycle of B. burgdorferi. As the
lipoproteins form an interface between inside and outside environment for borrelia, the delicate
balance of outer surface proteins play a central role in its survival (De Silva and Fikrig 1997b,
Schwan et al. 1995, Xu, McShan, and Liang 2008). The outer surface lipoproteins play a
collective role in adaptation of B. burgdorferi within the Ixodes tick vector and a mammalian
host (Xu, McShan, and Liang 2008), however, the survival strategies adopted by the Lyme
disease spirochetes are not completely understood.
The sophisticated regulation of the different surface lipoproteins by borrelia relies on complex
regulatory mechanisms. Though, borrelia has limited metabolic pathways as it evolved to
parasitize nutrients from its hosts, the molecular regulatory mechanisms are impressively
complex and hard to unravel (Fraser et al. 1997). The knowledge of the complex regulatory
pathways involving limited regulatory factors is still incomplete and is an open field for research.
The studies revealing new mechanisms of borrelial gene control are crucial to develop new
strategies to interrupt the spirochete’s life cycle and curb the emerging Lyme disease.
The outer surface lipoprotein A is abundantly expressed on the surface of B. burgdorferi as it
lays dormant within tick midgut, however there is rapid downregulation of this protein in
response to blood meal (Schwan et al. 1995). The vigorous downregulation of OspA is
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coordinated with upregulation of OspC (Schwan et al. 1995, Schwan and Piesman 2000). This
reciprocal expression of OspC and OspA is responsible for exit and transmission of borrelia from
the invertebrate tick vector to a mammalian host (Schwan et al. 1995). The 2010 publication by
Xu et al. reported a regulatory structure consisting of two sequences flanking the ospA promoter:
cisI and cisII, these two sequences provide B. burgdorferi with molecular mechanism to quickly
downregulate or upregulate OspA in response to changes in external environment. However, the
factors binding these sequences in response to specific environmental stimuli has not been
identified yet. As the downregulation of OspA is important for survival of B. burgdorferi within
the mammalian host, identification of underlying molecular mechanism may yield new strategies
to prevent transmission of Lyme disease (Strother et al. 2007, de Silva et al. 1997).
The homeostasis on the outer membrane layer of B. burgdorferi is exemplified by several studies
(Battisti et al. 2008, He et al. 2008, Pal et al. 2004). Crossregulation of OspA and OspC is one
classic well studied homeostatic expression, as it is central to establishment of the Lyme disease
and maintenance of the spirochete in enzootic life cycle (Schwan and Piesman 2000, Schwan et
al. 1995).
Goal, objectives, and hypothesis
Goal
The overall goal of this dissertation is to add to the current knowledge of gene regulation in the
Lyme disease agent and highlight the homeostatic maintenance of the surface lipoproteins on the
outer membrane layer of Lyme disease spirochete B. burgdorferi.
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Objectives
The specific objectives and hypothesis of the study are listed below:
1. To confirm the repression of OspA in bosR mutant and investigate if this repression is
directly mediated by BosR mediated or indirectly mediated by RpoS.
2. To find out specific region of ospA operon involved in BosR mediated repression.
3. To study osp expression in ospA mutant and identify the other surface lipoproteins that are
involved in maintaining the homeostasis of the outer surface lipoprotein layer in B.
burgdorferi.
Hypothesis
The hypothesis underlying the above mentioned objectives can be stated as following:
1. BosR is the repressor protein responsible for downregulation of OspA by direct action on
ospA operon.
2. The outer surface lipoprotein layer is in a state of homeostasis and loss of a dominant osp
like OspA shall cause upregulation of other osps to maintain the lipoprotein layer on borrelial
outer surface.
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CHAPTER 2
DIRECT ROLE OF BORRELIA BURGDORFERI OXIDATIVE
STRESS REGULATOR IN DOWNREGULATION OF OUTER
SURFACE PROTEIN A 1
Introduction
The enzootic infection cycle of B. burgdorferi has two phases: the tick phase and the mammalian
phase. Each phase requires distinct physiological adaptations. Rapid adaptation in response to
changing environmental signals by differential gene expression is the key survival strategy used
by B. burgdorferi (Samuels 2011, Radolf et al. 2012). Most of the differentially expressed genes
encode for the outer surface lipoproteins (Fraser et al. 1997). Thus, different outer surface
proteins (osp) are expressed in the tick and mammalian phase (Barbour, Tessier, and Hayes
1984, Pollack, Telford, and Spielman 1993). A prototypical example of the phase differential
expression of the surface lipoproteins can be seen in B. burgdorferi as it prepares to infect the
mammalian host. This involves downregulation of the dominant tick phase osp, OspA, and
upregulation of the mammalian phase osp, OspC (Schwan et al. 1995, Schwan and Piesman
2000).
The maintenance of coordinated outer surface lipoproteins requires intricate regulatory
mechanisms. B. burgdorferi has a small genome, which encodes very few transcription
regulators. Its only two known alternate sigma factors, RpoN (σN) and RpoS (σs), form a key
regulatory cascade. In this regulatory pathway, rpoS depends on RpoN for transcription
activation (Studholme and Buck 2000). Recent studies have added Rrp2 as the response regulator
protein controlling activation of RpoN (Yang et al., 2003).

1

A section (all materials pertaining to figures 2.4, 2.5, 2.6, & 2.7) of this chapter previously appeared as part of
publication: (Wang et al. 2013); it is reprinted with permission of wiley & sons. See the permission letter in
Appendix A & B
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The most recent addition to the unique molecular regulators of B. burgdorferi is BB0647. It was
initially known as borrelial Fur (Ferric uptake response) regulator protein, and is currently more
well accepted as BosR (Borrelia oxidative stress response Regulator,) due to its shared homology
with PerR protein (oxidative stress response repressor in Bacillus subtillis) (Hantke 1981, Bagg
and Neilands 1987).
Boylan et al. showed BosR to be a transcriptional activator in 2003. They determined that BosR
binds in-vitro to the upstream region of dps/napA and activates it.2 Furthermore, a 2009 study
indicated that BosR may function as a universal repressor and activator in B. burgdorferi
(Ouyang et al. 2009). The same study also showed that BosR is essential for causing infection in
the mammalian host, but not for persistence in the Ixodes tick vector (Ouyang et al. 2009). While
Ouyang et al. showed that loss of bosR also resulted in loss of expression of OspC and DbpA, a
seminal study by J. A Hyde et al. showed that this loss was due to the absence of RpoS (Hyde et
al. 2009, Ouyang et al. 2009). Thus, the role of BosR in RpoN-RpoS pathway was established as
a transcriptional activator, with a more recent 2011 study showing that BosR binds directly to the
upstream regulatory sequence of rpoS to effect its activation (Ouyang, Deka, and Norgard 2011).
RpoS is required for OspC up- and OspA downregulation, respectively (Caimano et al. 2005,
Yang et al. 2005); thus, BosR is considered a regulator protein that indirectly controls the
crossregulation of OspC and OspA in B. burgdorferi.
However, the studies before identification of BosR indicated that an unidentified 23kDa
repressor protein directly binds the ospA promoter, and therefore, may govern the OspA
downregulation (Margolis and Samuels 1995). Additionally, some recent studies have predicted
indirect RpoS mediated repression of ospA transcription via “a trans-acting DNA binding

2

NapA protein is known to protect B. burgdorferi from reactive oxygen species (Boylan, Posey, and Gherardini
2003).
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protein,” (Caimano et al. 2005, Caimano et al. 2007). Furthermore, recent studies have shown
that BosR is a 20 kDa DNA-binding protein required for the activation of the RpoS (Caimano et
al. 2007), which has prompted investigation of BosR as a plausible repressor protein for OspA.
The present study investigates the possible BosR mediated direct repression of OspA. Also, due
to known similar expression pattern in enzootic cycle of B. burgdorferi, OspD is also
investigated together with OspA repression in this study (Stewart et al. 2008).
The Outer surface proteins (Osps) A and B are encoded by a 2-gene operon (Fingerle et al.
2007). The expression of the ospA operon is driven by a (RpoD) σ70-dependent promoter
(Crother et al. 2004). B. burgdorferi cannot turn off this housekeeping σ factor in pursuit of the
rapid turnoff of the ospA operon. To do so would likely be lethal to B. burgdorferi. A 1999
publication by Sohaskey et al. suggested involvement of the T-rich region immediately upstream
of ospA promoter in regulation of ospA (Figure 2.1). A 2010 study in our lab identified two
regulatory elements: cisI and cisII, flanking the ospA promoter (Figure 2.1). In this study, both
these sequences were demonstrated to be required for ospA repression during the mammalian
infection. Thus, these sequences were demonstrated to equip B. burgdorferi with a molecular
mechanism for rapid adaptation within the distinct environments during its enzootic cycle
(Barbour et al. 1986). The successful identification of two regulatory sequences, namely cisI and
cisII, indicates the existence of a repressor(s), which should bind the two elements and shut off
the ospA expression during the murine infection (Raetz and Whitfield 2002).
The current study first shows that BosR bound both cisI and cisII, and then demonstrates that
increased BosR expression executed a complete switch off of OspA on the borrelial surface. The
current study interestingly demonstrates that one of the two putative BosR-binding sites
associated with the ospA operon is completely included within the previously identified cisII
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regulatory sequence (Labandeira-Rey, Seshu, and Skare 2003), while the second is partially
overlapped with the -10 region of the promoter (Grimm et al. 2004).
As an important regulator, BosR has a demonstrated function: it binds the rpoS promoter region
and positively regulates the alternative σ factor, which, in turn, upregulates a number of osps,
including OspC and DbpBA (Sears et al. 1991, Wang et al. 2013, Ouyang et al. 2009). Although
in vitro cultured B. burgdorferi doesn’t produce BosR during its early growth phase, once grown
to late log phase, the pathogen dramatically upregulates the regulator. However, this dramatic
BosR upregulation has been unable to associate with OspA downregulation, seriously
challenging the notion that BosR, in addition to the identified function described above, may also
function as a repressor of the ospA operon. The current study demonstrated that BosR binds both
previously identified regulatory elements of the ospA operon. Furthermore, the study showed that
increasing expression of BosR can completely turn the operon off when other major osps, such
as OspC, DbpA and DbpB, were constitutively expressed. Thus, the current study adds a new
important role of BosR as a repressor protein of ospA operon.
Material and methods
Growth conditions and harvest of B. burgdorferi
Borrelia burgdorferi was grown in 40 ml of Barbour-Stoenner-Kelly H (BSK) complete media
in 50 ml Falcon tubes at 33°C (5% CO2) to about 108cell/ml. Cells were then harvested by
centrifugation at 3711x g for 20 min at 4°C. The bacterial pellet was washed three times by
suspended in 40 ml cold HN (10 mM HEPES, 50 mM NaCl, pH 8.0) and centrifuged.
Supernatant were removed, pellet was further used to SDS-PAGE or 2-DE analysis or stored at 80˚C for future use.

36

Strains used for this study
The B. burgdorferi strains

constructed previously from B. burgdorferi type strain B31 by

Ouyang et al., 2009, and kindly provided by M.V. Norgard ( University of Texas Southwestern
Medical Center) were used (Ouyang et al. 2009). Mutant strains used included bosR lacking B.
burgdorferi B31, and bosR complemented strain.
Construction of pIBM-rpoSin, pME22-bosR’ and pME22-C’B’A’-bosR’
As diagrammed in figure.3.2 A , to construct pIBM-bosRin, a 554-bp DNA fragment covering
the entire coding region of the bosR gene was amplified by using primers P1F and P1R (Table
3.1) and DNA template extracted from B. burgdorferi B31. The resultant PCR product was
purified, digested with NcoI and XhoI, repurified and cloned into pIBM, which was created in a
previous study (Xu et al. 2012), and pre-digested with the same enzymes.
To construct pME22-bosR’, a plasmid that conferred constitutive BosR expression, a 597-bp
DNA fragment containing the entire coding sequence of the bosR gene was amplified using
primers P2F and P2R (Table 2.1) and DNA template purified from B. burgdorferi B31. The
resultant amplicon was purified, digested with BspHI and BamHI, repurified and cloned into
pME22, which was created in an earlier study(Shi et al. 2008), and pre-digested with NcoI and
BamHI. The construction process is summarized in figure. 2.2 B.
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Figure 2.1 Potential regulatory sequences upstream of the coding region of the ospA operon, including a pair of direct repeats, DR1
and DR2 (labelled with long arrows), a T-rich region (underlined with a solid line), and a sequence between the”10 region and the
start codon ATG (underlined with a dotted line). The ”35 and ”10 regions, putative ribosome-binding site (RBS), start codon ATG,
and stop codon TAA (all in bold type) are indicated. The +1 marks thepreviously identified transcriptional initiation site (Jonsson et
al., 1992). Picture from (Xu, McShan, and Liang 2010)
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To construct pME22-C’B’A’-bosR’, a plasmid that was able to provide constitutive BosR, OspC,
DbpA and DbpB expression simultaneously, two plasmids, pME22-bosR’ and pME22-C’B’A’
were used. The plasmid pME22-C’B’A’ was constructed in an earlier study (Grimm et al. 2004).
A 917-bp DNA fragment covering the promoterless bosR gene fused with the flaB promoter was
amplified from pME22-bosR with use of primers P3F and P3R (Figure 2.3C; Table 2.1).

A

10,059-bp DNA fragment harboring the promoterless ospC, dbpB and dbpA fused with the same
flaB promoter was amplified from pME22-C’B’A’ using primers P4F and P4R (Figure 2.3C;
Table 2.1). The resultant PCR products were pooled, purified, digested with NheI and PstI, and
ligated to complete construction of pME22-C’B’A’-bosR’.
Table 2.1: Primers used in this study
Primer

Sequences (5’ to 3’) a

P1F

AAATTCATGCCATGGACGACAACATAATAGACG

P1R

TTTCCGCTCGAGTCATAAAGTGATTTCCTTGTTCTC

P2F

AAATCATGAACGACAACATAATAGACGTACATTCC

P2R

AAAGGATCCACCAGTATTAAGAGTAATAAGAATATAAG

P3F

AAAGCTAGCAGGAAACAGCTATGACCATGATTAC

P3R

TGCCAAGCTTGCATGCCTGCAG

P4F

GACCTGCAGGCATGCAAGCTTGG

P4R

AAAGCTAGCGTCTTGATTATCGGGCGAAGAG

P5F

TAATTCCATATGAACGACAACATAATAGACG

P5R

TTTCCGCTCGAGTAAAGTGATTTCCTTGTTCTC

a

The underlined sequences are restriction enzyme sites: a BamHI sit (P2R), a BspHI site (P2F), a
NdeI site (P5F), a NcoI site (P1F), NheI sites (P3F and P4R), PstI sites (P3R and P4F), and XhoI
sites (P1R and P5R).
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Generation of transformants
The rpoS mutant, ΔrpoS, which was generated in our previous study (Grimm et al. 2004, Xu et
al. 2012), was grown to late logarithmic (log) phase in Barbour-Stoenner-Kelly H (BSK-H)
complete medium (Sigma). Spirochetes were harvested from approximately 40 ml of culture and
transformed with pIBM-bosRin, pME22-bosR’ or pME22-C’B’A’-bosR’ as described previously
(Xu et al. 2005). Transformants were identified by PCR using a primer pair specific for either
streptomycin or kanamycin cassette and their plasmid content was analyzed as described
previously (Xu et al. 2005).
Growth rate estimation
The spirochete culture was grown at 33°C to late log phase (approximately 108 cells/ml) in BSKH complete medium and diluted to 105 cells/ml with the medium. A total of fifteen 1.3-ml
aliquots were prepared and IPTG was then added to final concentrations at 0, 0.02, 0.05, 0.10
and 0.20 mM. Each inducer concentration was in triplicate. All aliquots were incubated at 33 oC
and cell numbers were counted daily for 10 days.

Either the parental clone 13A or the

transformant ΔrpoS/ΔrpoS was used as a control.
Host adaption of spirochaetes in DMCs
Mammalian host adapted spirochetes were prepared using dialysis membrane chambers (DMCs)
implanted intraperitonealy in Sprague Dawley as described by Akins previously (Akins et al.
1998). The rats used were were 6-8 weeks old and obtained from Division of Laboratory Animal
Medicine at Louisiana State University, Baton Rouge. All animal procedures described were
approved by the Institutional Animal Care and Use Committee at Louisiana State University.
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Figure 2.2. Construction of pIBM-bosRin, pME22-bosR’ and pME22-C’B’A’-bosR’. (A) To
construct pIBM-bosRin, a 554-bp DNA fragment covering the entire coding region of the bosR
gene was amplified. The resultant PCR product was cloned into pIBM. (B) To construct
pME22-bosR’, a 597-bp DNA fragment containing the entire coding sequence of the bosR gene
was amplified and cloned into pME22. (C) To construct pME22-C’B’A-bosR’, a 917-bp DNA
fragment covering the promoterless bosR gene fused with the flaB promoter was amplified from
pME22-bosR’. A 10,059-bp DNA fragment harboring the promoterless ospC, dbpB and dbpA
fused with the flaB promoter was amplified from pME22-C’B’A’. The resultant PCR products
were ligated to complete construction of pME22-C’B’A’-bosR’.
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The Spectra/Por® 6 Standard Grade Regenerated Cellulose dialysis membrane with molecular
weight cut-off of 8 kDa (Spectrum Laboratories, Rancho Dominguez, CA) was used for making
the dialysis membrane chambers. The dialysis membrane was treated with 5 mM EDTA to
remove any heavy metal impurities and was subsequently autoclaved. The dialysis membrane
chambers were filled with 5 ml of 103 spirochaetes per ml of spirochete containing BSK-H
complete media. The spirochetes were first cultured to late log phase and then diluted to 103/ ml.
Using standard aseptic techniques, sterile DMC was implanted into the peritoneum of rat, after 4
weeks of adaptation in DMCs, approximately 5 × 107 of the bosR mutant and 2 × 107 of the
complemented bosR mutant were recovered and subjected to immunoblot and q RT-PCR
analyses as described below.
Immunoblot and Coomassie analysis
Spirochetes were harvested from culture (both DMC & BSK-H) and pelleted by centrifugation at
5,000×g at 4oC. The spirochetes were then suspended in Laemmli buffer (Laemmli 1970) at
spirochetes to 2 × 105 spirochaete cells/μl. The sample was incubated at 100°C for 10 min. SDSPAGE was run using 5 μl of each sample. The SDS run samples were

transferred to

nitrocellulose membrane and were incubated with a mixture of FlaB mAb and mouse anti-BosR
sera or OspC mAb alone as described in our previous study (Xu et al. 2006) or pooled sera
(antibodies for FlaB, BosR, OspC, OspA, or OspD) from mice infected with B. burgdorferi B31
strain via tick infestation. Immunoblot reaction was performed using goat α-mouse IgGhorseradish peroxidase conjugate (Kirkegaard & Perry Laboratories) at a 1:10000 dilution and
developed using SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific) and
captured on X-ray films. For protein analysis, proteins separated on SDS-PAGE gels were
directly stained with Coomassie Brilliant Blue G-250 (Amresco, Inc., Solon, and OH).
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Quantitative RT-PCR and PCR
Total RNA was extracted from harvested spirochaetes using TRIZOL reagent (Life
Technologies) and treated with RNase-free DNase I (Roche) for complete digestion of possible
DNA contamination. In order to achieve highest purity RNA preparation was purified using
RNeasy mini spin column (Qiagen) following the manufacturers’ instructions.
For q RT-PCR analysis, RNA was first reverse transcribed into cDNA using Superscript™ III
reverse transcriptase (Life Technologies) and random hexamers. A mock reaction without
reverse transcription was also performed to ensure that preparation is DNA free. A standard
curve was generated by using a 10-fold dilutions of genomic DNA from known concentrations
B. burgdorferi and a linear standard curve was achieved. These standards were assayed in
triplicates to generate a linear calculation curve, which was used to convert the threshold cycle
(Ct) values into gene copy numbers of the test samples. Quantitative PCR was performed in 96well plates using SYBR® green PCR master mix (Applied Biosystems) and primers targeting
specific sequences (Table 2.1) using ABI 9500 thermal cycler and negative control in duplicates
were also added to the plate (Grimm et al. 2004), (Liang et al. 2004).
Expression and purification of recombinant BosR
The entire bosR-coding region was amplified from genomic DNA of B. burgdorferi B31 using
primers P5F and P5R (Table 2.1). Resultant PCR product was digested, purified and cloned into
pET-23a vector (EMD Chemicals Inc., Darmstadt, Germany), generating a construct that
contained the bosR-coding region fused with a C-terminal His6 tag.

One Shot®

BL21(DE3)pLysS Chemically Competent E. coli cells (Life Technologies, Grand Island, NY)
were transformed with the construct and induced with 1.0 mM isopropyl-beta-Dthiogalactopyranoside (IPTG) (Sigma Chemical Co., St. Louis, MO).
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Recombinant BosR was affinity-purified using HiTrap Chelating HP following the
manufacturer's instruction (GE Healthcare Bio- Sciences, Pittsburgh, PA). Protein concentration
were measured using Quick Start™ Bradford Dye Reagent following the manufacturer’s
instructions (Bio-Rad Laboratories, Hercules, CA).
Table 2.2: Oligos used for quantitative PCR assay
Name

Sequence (5’ – 3’)

flab + 441 Forward

AGCTGAAGAGCTTGGAATGC

flab + 543 Reverse

TTGGTTTGCTCCAACATGAA

bosR + 41 Forward

AAGTCGGCATTACAAACGAT

bosR +153 Reverse

TTTTGGGTTTGATGCTATGTAT

ospA +166 Forward

GCAACAGTAGACAAGCTTGAGC

ospA +295 Reverse

GTGTGGTTTGACCTAGATCGTCA

ospC +12 Forward

TACATTAAGTGCAATATTAATGACT

ospC +125 Reverse

AGATTAGGCCCTTTAACAGA

rpoS +108 Forward

AGGCAATGCAAAAGCAAAAA

rpoS +232 Reverse

ATCCCAAGTTGCCTTCTTGA

Electrophoretic mobility shift assay
To date, BosR has been shown to recognize sequences upstream of at least three other genes,
rpoS, bosR itself, and the gene encoding neutrophil activating protein A (NapA) (Liang et al.
2002, Katona et al. 2004, Ouyang, Deka, and Norgard 2011). Primers (Table 2.2) spanning 330
bps upstream and 20 bps downstream of the start of the ospA gene and 231 bps upstream and 68
bps downstream of the start of the ospD gene were designed (Table 2.2) and single band PCR
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products were used as probes for EMSA. Primers targeting upstream region of B. burgdorferi
genes ospA, ospD, rpoS, bicA, bosR, and ospC were designed and targeted regions were
amplified from B. burgdorferi type strain B31 using iProof DNA polymerase (Bio-Rad). Primers
labeled with biotin at 5′-end were used to generate biotinylated PCR fragments, which were then
purified on a 1.5% SeaPlaque (Lonza) agarose gel using the QIAquick gel extraction kit
(Qiagen) and DNA concentration was determined by absorbance at 260 nm and used as a probe
in EMSA. Each strand of the probes CisI, CisII, and IRs (Figure 2.3) was synthesized,
respectively, by Integrated DNA Technologies, Inc. (Coralville, Iowa). One strand of each
complementary pair was incorporated with 5’ Digoxigenin during synthesis. Complementary
strands were allowed to anneal to form a double-stranded probe.
Both the His6-tagged and the tag-free BosR were affinity-purified from E. coli as a soluble
recombinant protein and found to be active, His6-tagged BosR was used for EMSA assays.
For the density dependent competiton assay (Figure 2.6), the probes (1 nM) were incubated at
room temperature for 10 min with 5-, 10-, 20-, 40-, 80-, 160-, 320- or 640-fold molar excess of
BosR dimer in 20 μl reactions containing 10 mM Tris (pH 7.5), 50 mM KCl, 1 mM DTT, 5%
glycerol, 50 μg /ml salmon sperm DNA, and 100 μg/ ml of BSA. Annealing pairs of
complementary oligos were used as double-stranded competitor oligos (Table 2.2) in equi-molar
ratio. For competitor EMSA, BosR (320 nM of dimer) was incubated with 2-, 4-, 8-, or 16-fold
molar excess of a competitor prior to incubation with a probe (1 nM) and the binding reactions
were separated by electrophoresis on 6% polyacrylamide gels prepared in 0.5× TBE (Bio-Rad;
45 mM Tris, pH 8.3, 45 mM boric acid, 1 mM EDTA) and then transferred to nylon membranes.
The biotin signal was detected using Light Shift chemiluminescent EMSA kit (Thermo
Scientific) following the manufacturer's instructions.
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Figure 2.3. Diagram of cisI, cisII and putative BosR-binding sites of the ospA operon and three
probe sequences used in the study. (A) The location of cisI, cisII and putative BosR-binding sites
and the sequences of cisI and cisII probes. The regulatory sequences upstream of the coding
region of the ospA operon include cisI and cisII (both in bold) and two putative BosR-binding
sites (italic). One putative site is overlapped with the -10 region and the other is contained within
cisII. The -35 and -10 regions of the promoter, transcriptional initiation site, and start codon
ATG are underlined. The sequences of cisI and cisII probes are marked with brackets. (B) The
IRs were identified as the ospC operator in a previous study (Xu, McShan, and Liang 2007), and
used as a control probe. The sequence of the probe is marked with a bracket

The binding assay (Figure 2.8) reaction volume was set in a 20 μl, in which 1.0 nM DNA probe
was allowed to bind 400 nM of recombinant BosR at room temperature for 10 min. The binding
buffer contained 50μg/ml salmon sperm DNA, 100μg/ml BSA, 1.0 mM DTT, 50 mM KCl, 10
mM Tris (pH, 7.5) and 5% glycerol. In competition assay, 10 nM DNA competitor was first
added to a reaction volume of 20 μl and allowed to interact with 400 nM of recombinant BosR at
room temperature for 10 min before 1.0 nM DNA probe was supplemented and incubated for an
additional 10 min. Resultant mixtures were separated by electrophoresis on 10% polyacrylamide
gels prepared with 0.5× TBE buffer. Separated DNA was transferred to a nylon membrane and
probed using DIG High Prime DNA Labeling and Detection Starter Kit I as per the
manufacturer's instructions (Roche Applied Science, Mannheim, Germany).
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Table 2.3 Primers used to generate probes and competitive oligos for Electrophoretic mobility
shift assay (EMSA)
Name

5’-Label

Sequence (5’ – 3’)

53% G+C For

Biotin

CTATTCTGGACTACCTGCTGA

53% G+C Rev

CAATGTCTTTGCGTTTCGCTT

ospD -231 For

Biotin

AGCATCATTAAACATCCTTTCAATA CTCA

ospD +68 Rev

Biotin

ATCATGAACACAAGATATTGAGAGCAAT

Rnd Rev

CCCAGTCATCTTCATTGACTCATACCC

Fur For

GGGAAATGATAATAATTATCATTTGGG

Fur Rev

CCCAAATGATAATTATTATCATTTCCC

Per For

GGGAATTTATAATTATTATAAATTGGG

Per Rev

CCCAATTTATAATAATTATAAATTCCC

DR For

GGGTAAATTAAATTAAATTAAATGGG

DR Rev

CCCATTTAATTTAATTTAATTTACCC

RndAT Rev

CCCTTTATTTTAAATATATTATACCCTA

Per/7-0-7 For

GGGAATTTATAATATTATAAATTGGG

Per/7-1-7 Rev

CCCAATTTATAATATTATAAATTCCC

Per/7-2-7 For

GGGAATTTATAATTTATTATAAATTGGG

Per/7-2-7 Rev

CCCAATTTATAATAAATTATAAATTCCC

Rnd For

GGGTATGAGTCAATGAAGATGACTGGG

RndAT For

GGGTATAATATATTTAAAATAAAGGGTA

ospA -330 For

Biotin

ATCAAGACAAACATTGCTGCTTTAA

ospA +20 Rev

Biotin

CCCAATAAATATTTTTTCATAATATATTCTCCTT
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Table 2.3 Continued
Name

5’-Label

Sequence (5’ – 3’)

rpoS -277 For

Biotin

CTTGTGTTCTCTTACTGATTTTAAATATATGTTT

rpoS +60 Rev

Biotin

TGCTAAACGGAGGCCAAGTA

bosR -183 For

Biotin

TGTCGTTCATATGATTATACCTTTTTTGT

bosR +10 Rev

Biotin

CTGAATTCAAAAATAAAAAATTTAATTTTTTATACT

bicA -170 For

Biotin

TCTTCTTTTGTATCTATTTTATGCATT GT

bicA +159 Rev

Biotin

AGTTTTTTTGTGAATAACAAAGAAATTGGT

Rnd Rev

FAM

CCCAGTCATCTTCATTGACTCATACCC

RndAT Rev

FAM

CCCTTTATTTTAAATATATTATACCC

ospA -60 For

FAM

TAATCTTATAATATAATTATACTT

ospA -37 Rev
ospD -85 For

AAGTATAATTATATTATAAGATTA
FAM

ospD -60 Rev

ATAATTGATATTAAAATATAATTGAT
ATCAATTATATTTTAATATCAATTAT

ospA -330 For

FAM

ATCAAGACAAACATTGCTGCTTTAA

ospA +20 Rev

VIC

TTCCCAATAAATATTTTTTCATAATATATTCTCCTT

Results
Repression of OspA and OspD in mammals requires BosR
To determine the OspA repression in BosR lacking B. burgdorferi, the bosR mutant and the
isogenic complemented bosR mutant were cultivated in the DMCs implanted within the rat
peritoneal cavity. The bosR mutant did not express OspC and several other lipoproteins that are
expressed in the mammalian host, but the levels of these proteins were restored in the
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complemented bosR mutant (Figure 2.4). Also OspA and OspD protein levels were different for
the two variants ,while the bosR complement repressed OspA and OspD expression when
adapted in DMC just like its parental B31 background (Akins et al. 1998, Brooks et al. 2003) the
bosR mutant failed to do so (Figure. 2.4).
Quantification of the immunoblot bands showed that the relative OspA and OspD protein levels
were 3.8-fold and 3.5-fold higher, respectively, in the bosR mutant than in the complemented
bosR mutant (after normalization against the FlaB protein level) (Figure 2.5A).
Quantitative reverse transcription-polymerase chain reaction (q RT-PCR) was performed to
determine whether these differences at the protein levels could be observed at mRNA. After
normalization against the flaB mRNA level, the relative ospA and ospD mRNA levels were 2.7fold and 5.5-fold higher, respectively, in the bosR mutant than in the complemented bosR mutant
(Figure 2.5B).
The data above clearly shows that absence of BosR causes significant increase in the ospA and
ospD mRNA levels, which may be responsible for increase in the OspA and OspD protein levels.
The experimental results shown here suggest that OspA and OspD fail to be repressed in absence
of BosR. As absence of BosR causes absence of RpoS, these results are consistent with previous
studies (Hyde et al. 2009, Ouyang et al. 2009, Caimano et al. 2005).

49

Figure 2.4. OspA and OspD repression in DMC requires BosR. The bosR mutant (mut.) and the
complemented bosR mutant (comp.) were cultivated for 4 weeks in DMCs implanted in rat
peritoneal cavities and immunoblot analyses were performed using pooled sera from mice
infected with B. burgdorferi type strain B31 through tick infestation (α-B31) as well as
antibodies specific to FlaB, BosR, OspC, OspA, and OspD.

Figure 2.5: BosR dependent down regulation of OspA and OspD DMC: The bosR mutant (mut.)
and the complemented bosR mutant (comp.) were cultivated for 4 weeks in DMCs implanted in
rat peritoneal cavities and then subjected to protein and RNA analyses. (A) Relative protein
levels of BosR, OspC, OspA, and OspD (after normalization against the FlaB level) in the bosR
mutant as compared with those in the complemented bosR mutant. Data above is based on
quantification of the immunoblot results shown in figure 2.4. (B) The mRNA levels of bosR,
ospC, ospA, and ospD (after normalization against the flaB mRNA level sample) in the bosR
mutant as relative to their respective levels in the complemented bosR mutant. Data were based
on triplicate qRT-PCR analysis of the RNA samples obtained from the same DMC-adapted
bacterial samples that were subjected to immunoblot analyses in Figure 2.4.
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The above results indicate indirect role of BosR in downregulation of OspA and OspD.
However, BosR homology to family of transcriptional regulators (FuR) known to function as
repressors (Cullen, Haake, and Adler 2004, Fung et al. 1994) and more common role of sigma
factors like RpoS in transcription activation suggest an alternative explanation for the increased
ospA and ospD mRNA levels, which is, BosR may be repressing the ospA and ospD transcription
direclty by interacting with the promoter regions .
BosR binds directly to sequences upstream of the ospA operon and the ospD gene
BosR-binding to PrpoS, PbosR, and PbicA was compared to PospAB and PospD binding as to date, BosR
has been shown to recognize sequences upstream of at least three other genes, rpoS, bosR itself,
and the gene `encoding neutrophil activating protein A (NapA) now called BicA, Borrelia ironand copper-binding protein A (Liang et al. 2002, Katona et al. 2004, Ouyang, Deka, and Norgard
2011). Sequences upstream of the ospC gene (as it is RpoS regulated) and two unrelated genes
from Ehrlichia chaffeensis (ech193 and ech818) were included as negative controls in this
experiment. Weaker but nonetheless dose-dependent BosR binding to PospC, Pech193, and Pech818
was detected. As BosR did not bind to the synthetic probe that was 53% G+C probe (P G+C)
while it did bind to all other probes in this study (which were AT rich) the minimal BosR
binding to PospC, Pech193, and Pech818 could be attributed to propensity of BosR to bind AT- rich
sequences (Figure 2.6A ). Thus conclusively to the EMSA results it can be stated that despite
having a propensity for AT-rich sequences, BosR binds to sequences upstream of the ospA
operon and the ospD gene, much more strongly than to the upstream of the ospC gene.
The EMSA for dose dependent BosR binding to probes based upon the upstream sequences of
ospA operon and the ospD gene (PospAB and PospD) demonstrated that BosR readily binds to
these regulatory regions (Figure 2.6 A, B & C).
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Figure 2.6. BosR directly binds to sequences upstream of the ospA and the ospD genes. BosR
binding to PospAB, PospD, PrpoS, PbicA, PbosR, PospC, Pech193, Pech818, and P53%G+C was analysed by
EMSA. Probes (1 nM) were first incubated with BosR (5–640 nM of dimer) and then separated
on 6% polyacrylamide gels in 0.5× TBE.

Figure 2.7. Relative binding of BosR to PospA and PospD: BosR binding curves for PospAB (closed
circle), PospD (closed square), PrpoS (closed triangle), PbicA (closed diamond), PbosR (open circle),
PospC (open square), Pech193 or Pech818 (open triangle), and P53%G+C (open diamond) were generated
based on quantification of the EMSA data shown in Figure 2.6. Fraction of probe bound by BosR
in each reaction was calculated by dividing the intensity of all shifted bands (indicated with a
bracket) with the total intensity of both the shifted bands and the unbound band (indicated with a
line). In some probes, there were minor isomers (indicated with asterisks) that migrated slower
and were often not recognized by BosR. These isomers were excluded in the quantitative
analysis. For clarity, curves for the B. burgdorferi probes were indicated with solid lines, and
curves for the non- B. burgdorferi probes were indicated with dashed lines.
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The ospA regulatory sequences, cisI and cisII, bind BosR, albeit cisII shows much stronger
binding
Our previous study identified two regulatory sequences, one located upstream of the ospA
promoter, cisI, and the second between the promoter and the translational start codon, cisII,
regulating the downregulation of ospA expression as B. burgdorferi prepares to infect the
mammalian host (Xu, McShan, and Liang 2010). Also the above results (Figure 2.6) have
indicated the existence of two putative BosR-binding sites associated with the ospA locus. One
of the sites is completely included within cisII and the second covers the entire -10 region of the
ospA promoter and the first two base pairs of cisII (Figure 2.1 & 2.3). As the second site of the
14-bp putative BosR-binding sequence is overlapped with the -10 region, it is impossible to
entirely remove it without inactivation of the ospA promoter. For this particular reason, only 2
bps of this putative binding site were identified as a part of cisII in the previous study (Liang et
al. 2002).
The regulatory sequence cisI contains no putative BosR-binding site but showed a critical role in
repression of ospA transcription during murine infection, albeit it is less effective than cisII in
this regard (Xu, McShan, and Liang 2010). To examine if the previously identified regulatory
elements were able to bind BosR, three 70-bp DNA probes, namely probes cisI, cisII and IRs,
respectively, were synthesized as diagrammed in figure 2.3 Probe cisI covered the entire cisI
sequence and additional 14 bps down- and upstream sequences. Probe cisII included the entire
cisII sequence and extended upstream to include the -35 region of the ospA promoter. Probe IRs
contained the ospC IRs and extended few bps up- and down-stream to make up a total of 70 bps.
The IRs sequence was previously identified as an operator of the ospC gene and was not
expected to bind BosR, and thus was chosen as a negative control (Xu, McShan, and Liang
2007). To minimize nonspecific DNA interaction with BosR, the binding buffer was
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supplemented with 50μg/ml salmon sperm DNA. As shown in figure2.8 the presence of sperm
DNA completely eliminated the interaction of IRs probe with BosR. In contrast, the mobility of
both cisI and cisII probes was completely restrained by BosR, a result that clearly indicates that
both cisI and cisII are able to effectively bind BosR.
Excessive BosR expression causes cell death in B. burgdorferi
To artificially regulate BosR expression, pIBM-bosRin was constructed as illustrated in figure2.2.
Within the construct, BosR expression was under control of an inducible promoter. The BosR
production cannot occur due to the construct in the absence of the inducer IPTG, although the
native bosR gene may produce BosR as normal.

Figure 2.8. Both the regulatory sequences of the ospA operon, cisI and cisII, bind BosR and cisII
shows stronger binding: The binding buffer contained 50μg/ml salmon sperm DNA. The ratio of
a DNA probe and a competitor was set at 1:10 (1.0/10 nM). Mobility shift analysis was
performed with 10% polyacrylamide gels.
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The plasmid pIBM-bosRin was easily introduced into ΔrpoS, which was used because any RpoS
involvement in OspA downregulation was readily ruled out in this way. The plasmid pIBMbosRin was also electroporated into 13A, the parental clone of ΔrpoS, as a control. In a single
transformation experiment with ΔrpoS, five transformants were obtained. Plasmid analyses led
to the identification of one clone, namely, ΔrpoS/bosRin, which lost cp9, lp5, lp21, lp25 and lp56
as ΔrpoS, in addition to lp28-1. Transformation of 13A led to selection of 7 transformants, one
of which, namely 13A/bosRin, lost cp9, lp5, lp21, lp25, lp56 and lp28-1 and was chosen for
further studies. There had been no evidence that any of the lost plasmids affects gene regulation
although both lp25 and lp28-1 are critical for murine infection (Xu, McShan, and Liang 2007).
A recent study reported that increasing RpoS expression causes cell death (Chen at el 2013). To
investigate whether high BosR expression is toxic, both ΔrpoS/bosRin and 13A/bosRin were
grown to early log phase (107 cells/ml) in BSK-H medium and diluted to 105 cells/ml before
IPTG was added to a final concentrations ranging from 0 to 0.2 mM. When IPTG reached as
low as 0.05 mM, ΔrpoS/bosRin growth was affected negatively (Figure 2.9A). When the
concentration increased to 0.1 mM, growth was essentially arrested within a couple of days after
induction and all spirochetes eventually died within a week. Although at lower concentrations
IPTG did not affect early growth, its presence reduced the stationary cell density.
13A/bosRin was little less sensitive than ΔrpoS/bosRin to induction with IPTG. At 0.1 mM, the
inducer showed little effect on growth (Figure 2.9B). Even at 0.2 mM, spirochetes continued to
grow for a couple of days and then started to die and induced spirochetes became uncountable
within a week.
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Inducing BosR expression leads to dramatic downregulation of OspA
As shown above, excessive BosR expression caused a lethal consequence to B. burgdorferi. At
0.2 mM, IPTG significantly inhibited both ΔrpoS/bosRin and 13A/bosRin shortly after the
induction and eventually killed them within a week.

This concentration was chosen to

investigate how induction of BosR influenced OspA expression.
The ΔrpoS/bosRin and 13A/bosRin spirochetes were grown to 107 cells/ml and then IPTG was
supplemented to 0.2 mM. The IPTG induction was allowed for 3 days before spirochetes were
harvested and analyzed. During this time, the spirochete density reached 108 cells/ml, reflecting
a 3-fold increase. As shown in figure 2.10, as BosR was induced, OspA expression was
dramatically reduced in ΔrpoS/bosRin. A less prominent effect of induced BosR expression on
OspA downregulation was observed in 13A/bosRin.
It should be noted that OspA may be pretty stable in live cells and thus reduction in detected
protein amount might primarily depend on the dilution effect of cell division. The total bacterial
number increased approximately 3 times after induction. Therefore, reduction in OspA amount
might not be more than 3-fold even if the transcriptional process could be fully stopped
immediately upon induction. Moreover, the abundant ospA mRNA accumulated before induction
would continue to be translated into protein until they were degraded.
Total RNA was also prepared and analyzed. As shown in figure 2.10 C, induced BosR
expression led to more than 86% reduction in ospA transcription in ΔrpoS/bosRin and 65% in
13A/bosRin. Unlike protein, mRNA is less stable and its level would better reflect the magnitude
in ospA gene downregulation resulting from increased BosR expression.
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Figure 2.9. Excessive BosR expression causes cell death: (A) A total of 15 1.3-ml aliquots of
ΔrpoS/bosRin spirochetes at a density of 105 cells/ml were prepared and supplemented with IPTG
to final concentrations at 0, 0.02, 0.05, 0.10, and 0.20 mM. Each sample was incubated at 33 oC
and assayed in triplicate. The cell numbers were counted daily for 10 days. Mean counts
presented here were calculated from the triplicates of each treatment. The ΔrpoS/rpoS
spirochetes were used as a control. (B) The same experimental design was used to examine the
13A/bosR’ spirochetes when the parental clone 13A was used as a control.
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Figure 2.10. Inducing BosR expression leads to dramatic downregulation of OspA: (A&B). Both
ΔrpoS/bosRin and 13A/bosRin spirochetes were grown to a density of 107 cells/ml and then
supplemented with IPTG to a final concentrations at of 0 or 0.2 mM. Induction was allowed for
3 days. Treated bacteria were harvested and analyzed either by immunoblotting probed with a
mixture of FlaB mAb and mouse BosR antibodies (A, upper panel) or with OspC mAb alone (A,
lower panel), or Coomassie staining (B). (C) Total RNA was extracted from induced and
noninduced spirochetes 24 hours after initial treatment, converted to cDNA and analyzed by
qRT-PCR.
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Although induction led to a dramatic increase in BosR production, OspC expression didn’t
significantly increase (Figure 2.10), probably because RpoS was also positively regulated by
other regulators, such as RpoN, small RNAs and Badr (Miller, Karna, and Seshu 2013, Lybecker
and Samuels 2007, Hubner et al. 2001, Samuels 2011). An unbalanced increase in BosR
expression might not overwhelm RpoS expression if expression of RpoN was not dramatically
mobilized.
Increasing BosR expression completely shutoffs OspA production when constitutive
expression of other Osps simultaneously occurs
Increasing BosR expression leads to dramatic downregulation of OspA but is never able to shut
off expression, even when BosR expression was induced to a toxic level.

To completely

downregulate OspA with increased BosR, we designed an experiment based on our hypothesis
that the Osp layer homeostasis of B. burgdorferi overwrites the normal regulatory programs. In
other words, as OspA/B are so dominantly expressed osps in cultured spirochetes, B. burgdorferi
cannot completely downregulate them without dramatically increasing expression of other osps.
To continue to address the hypothesis, two additional constructs, pBBE22-bosR’ and pBBE22C’B’A’-bosR’, were created as shown in figure 2.2 B & C. Within the former, the fused bosR
gene was designed to express under the control of flaB promoter, while in the latter, in addition
to a fused bosR gene, three osp genes, ospC, dbpA and dbpB, were all engineered to transcribe
under control of a fused flaB promoter. After the two constructs were introduced into ΔrpoS,
five and eight transformants were obtained, respectively. Plasmid analysis led to identification
of two clones, namely, ΔrpoS/bosR’ and ΔrpoS/C’B’A’-bosR’, which lost cp9, lp5, lp21, lp25
and lp56 as ΔrpoS, in addition to lp-28-1. As shown in figure 2.11B, a high level of BosR
expression driven by the fused flaB promoter greatly downregulated OspA but was unable to
completely shutoff its expression, consistent with the results obtained above with the inducible
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promoter shown in figure 2.10 B. Whereas the simultaneous expression of OspC, DbpA and
DbpB, along with the constitutive BosR production led to successful shutoff of OspA production
(Figure 2.11B).

Figure 2.11. Increasing BosR expression shuts off OspA production only when other osps, OspC,
DbpA and DbpB, are constitutively expressed: The ΔrpoS, ΔrpoS/bosR’ and ΔrpoS/C’B’A’bosR’ were grown to early log phase (108 cells/ml), harvested and analyzed either by
immunoblotting & probed with FlaB and BosR antibodies (A), or by Coomassie staining (B).

60

Discussion
The in-vitro BSK-H cultivated B.burgdorferi shows simultaneous expression of OspA, OspC,
and OspD. Downregulation of OspA requires mammalian host specific signals, even in nature
only a part of the spirochetes colonizing tick vector midgut downregulate OspA in response to
blood meal and migrate to the salivary glands and infect the mammalian host. Thus in order to
understand the mechanism of OspA downregulation it is very important to provide mammalian
host environment to B. burgdorferi strains involved in this study. In order to see difference in
expression of the outer surface lipoprotein layer between bosR mutant and bosR complement
strain, both were incubated in DMCs implanted in the rat peritoneum (a technique providing
mammalian physiological signals). Consistent with previous reports, OspC expression was
absent in host adapted bosR mutant while it was expressed in bosR complement.This further
confirms the requirement of BosR for OspC expression (Hyde et al. 2009, Ouyang et al. 2009).
Further, just like the wild type B. burgdorferi B31 adapted in DMC, OspA and OspD were
downregulated in bosR complement (Akins et al. 1998, Brooks et al. 2003). Based on these
expression differences for OspC, OspA, and OspD it was confirmed that both bosR mutant and
bosR complement spirochetes were optimally mammalian host adapted for further analysis.
Based on the electrophoretic mobility shift assay results, this study demonstrated that BosR
directly binds to sequences upstream of the ospA and the ospD. This upstream region of ospA
operon have been shown in a previous 2010 study by our lab to be involved in OspA regulation
(Xu, McShan, and Liang 2010). The present study indicates that BosR is capable of producing
repression of OspA by direct binding to its promoter region and hence acts as a repressor for it.
Until now OspA downregulation has been considered to be regulated by RpoS, as the study by
Caimano et al. had demonstrated that loss of rpoS in B. burgdorferi also resulted in lack of OspA
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repression within the mammalian host (Caimano et al. 2007). The requirement of RpoS for
downregulation of OspA in addition to newly found direct OspA repressor function of BosR
suggests that, BosR alone is not sufficient for OspA repression. In an unfed tick OspA is the
most abundantly expressed osp on the borrelia surface. A previous study in our lab showed that
expression of osps plays an important protective role in maintenance of viability of spirochetes.
As shown in various studies, the outer surface lipoproteins may be expressed in accordance to a
certain level of homeostasis of the outer surface. B. burgdorferi mutants have shown
compensatory upregulation of osps supporting the surface homeostasis theory for example, a
2008 study by He et al. demonstrated that the deletion of ospA operon in B. burgdorferi lead to
constitutive activation of Rrp2-RpoN-RpoS pathway and thus constitutive expression of OspC
(He et al. 2008). However, in a similar study, parental B31 as well ospA mutant did not show
OspC expression, showing increased level of several other outer surface proteins (Battesti,
Majdalani, and Gottesman 2011). This study also indicated that OspC was not a unique
compensatory osp. Another study also reported example of compensatory osp upregulation in B.
burgdorferi (297 strain) ospC mutant, in which several other lipoproteins were found to be
upregulated under the RpoS regulon like DbpA, DbpB, and BBK32 (Pal et al. 2004).
In each of the above mentioned studies, different strains of B. burgdorferi appeared to
compensate the loss of one or the other lipoprotein with increased expression of other
lipoproteins. Therefore, it is possible that deficiency of RpoS-mediated outer surface lipoproteins
cause immense pressure on spirochete to maintain expression of tick phase surface lipoproteins
(OspA and OspD). Nonetheless, BosR most probably acts as a repressor for ospA.

The lipoprotein nature and dominant expression of OspA makes it highly immunogenic and thus
elicits a strong mammalian immune response (Barthold et al. 1995, Weis, Ma, and Erdile 1994).
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Though, the mammalian OspA antibodies may not effectively eliminate B. burgdorferi from host
tissues but can still prove fatal for spirochetes when acquired by the infected tick vector along
with blood meal, this may eventually lead to disruption of borrelial enzootic cycle (de Silva et al.
1996, de Silva et al. 1999). Thus, in order to maintain itself in the natural cycle B. burgdorferi
must rapidly downregulate OspA and evade immune detection in the mammalian host. The
present study elucidates the mechanism of OspA downregulation and demonstrates that BosR
binds the regulatory elements namely cisI and cisII on the ospA operon and shuts down the OspA
expression on borrelial surface. Hence we can state that BosR functions as a repressor and the
two regulatory elements, cisI and cisII, serve as operators of the ospA operon.
A previous study in our lab identified cisI and cisII as the two regulatory sequences flanking
ospA operon that are required to produce maximum downregulation during murine infection (Xu,
McShan, and Liang 2010). This study also demonstrated that downregulation mediated by cisII
was four fold more effective than by cisI (Xu, McShan, and Liang 2010). Hence the findings of
present study are in congruence with the previous results. It was observed that both cisI and cisII
elements bind BosR and indeed cisII binding was much stronger than that mediated by cisI. This
double-operator system, comprised of cisI and cisII sequences, use BosR as a common repressor
and enables the complete shutoff of ospA operon, and thus provides B. burgdorferi with a
protective mechanism to hide from host immune system and maintain its enzootic infection
cycle.
BosR is required for expression of RpoS, which in turn activates ospC, dbpBA and many other
osp genes (Hyde et al. 2009, Ouyang et al. 2009, Wang et al. 2013). The regulator is not
expressed in early growth phases but is dramatically upregulated in late log phase. There has
been no significant OspA downregulation observed in cultured spirochetes although BosR
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expression is considered reaching the highest level in late log phase. Even in the vector tick’s
midgut, no more than 50% of the spirochete population downregulate OspA during any period of
blood meal although most of the remaining population express OspC abundantly, an indication
that BosR is actively expressed (Purser and Norris 2000). It is not an easy task to downregulate
OspA although B. burgdorferi readily shuts off OspA either during mammalian infection or
while being grown in host-adapted conditions (Barthold et al. 1995, Akins et al. 1998). These
previous observations foretold what we experienced in the present study. To induce OspA
downregulation, we increased BosR expression to a level that nearly kills B. burgdorferi. Under
this in-vitro condition OspA expression is significantly downregulated but is not completely shut
down.
The survival of B. burgdorferi within its two very distinct host environments demands
deployment of complex survival strategies. All the adaptive changes taken up within its enzootic
cycle are a consequence of dramatic differential gene expression of B. burgdorferi. Under the
normal conditions, complete OspA downregulation occurs only during mammalian infection, in
which OspC and other many RpoS-dependent osps are dramatically upregulated. The
mammalian host apparently provides an extreme environment as these specific alternation
signals might be unachievable under any in-vitro conditions. While either excessive RpoS or
BosR expression is lethal to B. burgdorferi in-vitro, these high levels of expression may be
essential for the pathogen to achieve downregulation of the ospA operon and to greatly
upregulate RpoS-dependent virulence factors, and ultimately allow better survival of B.
burgdorferi in the mammalian host. To achieve OspA downregulation in B. burgdorferi grown
in-vitro, a high level of BosR expression in combination with simultaneous expression of OspC
and other osps may be required.
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As a key regulator, BosR, like RpoS, must be strictly regulated. The present study showed that
BosR causes cell death when expressed at a very high level, just like RpoS (Chen et al. 2013).
The cell death caused by excessive RpoS expression may be simply attributed to σ factor
competition but there is no simple explanation for BosR-related death. While the biological
significance of induced cell death remains to be addressed, at least one possibility should be
considered, that is to control cell populations less diverse in the same environment. For instance,
the death strategy would select out subpopulations with a phenotype that overexpresses RpoS- or
BosR-dependent genes during the stage in the tick vector. However, cell death resulting from
increased RpoS or BosR expression is observed in-vitro. Given that B. burgdorferi cycles
between the extremely different environments encountered in the tick vector and a mammal, invitro growth conditions may only constitute an abnormal environment. It is possible that a high
level of BosR and RpoS expression may provide an essential strategy for the pathogen to
survive. Especially during infection of the mammalian host, B. burgdorferi may have to
upregulate produce high levels of BosR to shutoff OspA expression and upregulate RpoSdependent virulence genes in order to adapt to the hostile environment inside host tissues.
An RpoS-deficient background was chosen initially to rule out any involvement of RpoS in
OspA downregulation, as a previous study suggested the alternative σ factor may be involved in
regulation (Eggers, Caimano, and Radolf 2004). BosR positively affects expression of many
osps, including OspC and DbpA/B through activation of RpoS expression (Hyde et al. 2009,
Liang, Nelson, and Fikrig 2002). We speculated that induced BosR expression might cause
downregulation of OspA more effectively in 13A/bosRin than ΔrpoS/bosRin, as BosR also
increases RpoS expression, which increases OspC and DbpAB expression and increased
production of these osps would compensate for the loss of OspA. However, the present study
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showed that induced BosR causes OspA downregulation in ΔrpoS/bosRin than in the 13A/bosRin
mutants, suggesting that gene regulation in B. burgdorferi is more complicated than believed
previously. Our immunoblotting experiment showed that BosR expression is significantly
stronger in the RpoS-deficient background than in the 13A/bosRin, suggesting that the presence
of RpoS might exert a feedback pressure on BosR expression.
BosR acts as a critical regulator as it directly binds the rpoS promoter region and activates rpoS
transcription along with other regulators, RpoN and Rrp2. The current study demonstrated that
BosR shuts off OspA expression by directly binding to the two regulatory sequences of the ospA
operon. The question that how BosR can function as an activator as well as repressor remains to
be investigated and thus may form a basis for future studies in the field. A previous study in our
lab which identified cisI and cisII showed that these two elements could enhance ospA
transcription in spirochetes cultured under in-vitro conditions. Although this enhancement was
very minor, it supports the activator function of BosR. Thus there is another aspect to the
regulatory function of BosR which remains to be uncovered when it is expressed at relatively
low levels.
In continuation to the previous publication from our lab which identified cisI and cisII as the
genetic elements required for downregulation of ospA within the murine hosts (Xu, McShan, and
Liang 2010); the present study elaborately demonstrates the repressor function of BosR for the
ospA operon. This study demonstrates direct binding of BosR to both cisI and cisII regulatory
elements and resulting into a complete shut down of OspA expression. This data contribute
further to the series of studies by other groups showing that BosR directly binds to rpoS
promoter region and causes upregulation of several RpoS regulated osps on the borrelial
surface(Sears et al. 1991, Ouyang, Deka, and Norgard 2011). In conclusion BosR acts as an
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important gene coordinator, which on one hand causes upregulation of RpoS-dependent OspC,
DbpA, and DbpB and on the other hand leads to a direct repression of OspA expression.
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CHAPTER 3
OUTER SURFACE LIPOPROTEIN LAYER HOMEOSTASIS
OVERRIDES NORMAL REGULATORY PROGRAMS IN
BORRELIA BURGDORFERI
Introduction
Unlike other Gram-negative bacteria, which make a thick LPS (Lipopolysaccharide) coat or
Gram-positive microorganisms, which cover and protect themselves with a strong cell wall, B.
burgdorferi expresses lipoproteins and anchors them to the outer membranous surface through
lipidation (Cullen, Haake, and Adler 2004, Fung et al. 1994, Xu et al. 2005). Accumulating
evidence indicates that B. burgdorferi maintains its overall surface lipoprotein expression during
the entire enzootic life cycle i.e. travelling between the tick vector and a mammal, and during the
course of mammalian infection. The Lyme disease pathogen abundantly expresses outer surface
protein A (OspA) in the unfed tick (Takayama, Rothenberg, and Barbour 1987, Liang et al. 2002,
He et al. 2008, Xu et al. 2012). A fresh blood meal induces downregulation of OspA and the
upregulation of OspC and other osps, a process that prepares B. burgdorferi for infection in
mammals (Schwan et al. 1995, Ohnishi, Piesman, and de Silva 2001, Liang, Nelson, and Fikrig
2002, Purser et al. 2003). Abundant OspC expression ultimately induces a robust early humoral
response that imposes tremendous pressure on the pathogen (Schwan and Piesman 2000, Sears et
al. 1991). To evade the specific humoral response and cause persistent infection, B. burgdorferi
down-regulates OspC, and dramatically upregulates other surface lipoproteins, including VlsE
and BBF01 (Liu et al. 2009, Grimm et al. 2004, Mbow, Gilmore, and Titus 1999, Pal et al.
2004).
The outer surface lipoprotein expression is vital for B. burgdorferi as the failure to maintain
appropriate surface lipoprotein expression can be of a lethal consequence (Xu, McShan, and
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Liang 2008). B. burgdorferi highly expresses OspA in culture and shuts off the genes in response
to overwhelming ospA repressing mammalian signals after introduction into the host. The
inability to timely upregulate OspC to compensate for the loss of OspA and other osps results in
quick elimination of the ospC mutant (Ohnishi, Piesman, and de Silva 2001). This occurs when
OspC-deficient spirochetes are inoculated into mice.

Modification of the mutant with

constitutive expression of any of the four lipoproteins, OspA, DbpA, VlsE or OspE, successfully
rescues the ospC mutant with infectivity (Purser and Norris 2000).
The importance of surface lipoprotein layer homeostasis was also observed in vitro, although
interpreted in a different way, Yang and colleagues reported that inactivation of the ospA operon
leads to constitutive activation of RpoS expression (de Silva et al. 1996) . This occurs most
likely as the alternative σ factor, RpoS, controls many outer surface lipoproteins, including
OspC, DbpA/B, and BBK32 (Caimano et al. 2004, Caimano et al. 2005, Caimano et al. 2007).
Thus, the deletion of the operon that encodes the two most abundantly expressed Osps in vitro
(ospA) could be fatal to B.burgdorferi, unless other Osp(s) is dramatically upregulated to
compensate for the loss of OspA. As a result, only ospA mutants that happen to dramatically
upregulate other osps can survive and be selected for further propagation.
Although accumulating evidence supports the hypothesis that the outer surface lipoprotein layer
homeostasis is an overwhelming force to override the normal regulatory programs, no
experiments have been ever designed to specifically address this. In the present study, a series of
experiments were designed to directly examine this hypothesis, in addition to showing osp
homeostasis exists in B. burgdorferi.
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Material & methods
Strains and constructs that were generated previously and used in the current study
B. burgdorferi B31 (strain 13A) was used as wild type strain. The ospA mutant (ΔospA) and
ospA complement (ΔospA/ospA) were generated in a previous study (Xu, McShan, and Liang
2008). The shuttle vector pBBE22 was a gift from S. Norris (Liang et al. 2004).
2-D electrophoresis
This analysis was performed using the Bio-Rad 2-D system (Bio-Rad, Hercules, and CA)
following the manufacturer’s instructions. Briefly, B. burgdorferi was grown to late log phase
(approximately 108 cell/ml) in 1.0 ml BSK-H complete medium at 33oC and harvested by
centrifugation 5,000 ×g for 3 min. Resultant pellets were washed twice with 2-D washing buffer
by centrifugation and resuspended in ~150 μl preheated (95°C) SDS sample solubilization
buffer. After sonication, the sample was heated at 95°C for 5 min, cooled to 20°C, diluted with
~500 μl of 2-D sample solution, kept at room temperature for 20 min, and centrifuged at 14,000
×g for 30 min at 20oC. The protein concentration of the supernatant was determined and was
adjusted at ~5 μg/μl with 2-D sample solution.
First-dimension separation is performed by isoelectric focusing (IEF) electrophoresis. The premade IPG strip from Bio-Rad were used. IPG strip was rehydrated in rehydration/equilibration
trays followed by IEF with gel-side up.
Second-dimension separation is SDS-page. Equilibrate the IPG strips twice, each time for 10
min, in two different equilibration buffers. In sealing IPG Strips onto SDS-PAGE Gels, the
equilibrated IPG strips were placed on the top of polyacrylamide gels and SDS-PAGE was
performed.
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Total Protein Staining was performed with Coomassie or SYPRO Ruby Protein Gel Stain.
Mass spectrometry
Selected proteins from 2-D gel were analyzed by gel trypsin digestion and Matrix-assisted laser
desorption/ionization (MALDI TOF/TOF). MALDI was done in Nevada Proteomics Center, in
Reno, Nevada. The Spots or bands were excised with robot and digested using a previously
described protocol (Rosenfeld et al. 1992, Finehout and Lee 2003). Selected proteins from this
step were also analyzed by gel trypsin digestion and MALDI TOF/TOF. Samples were washed
twice with 25mM ammonium bicarbonate (ABC) and 100% acetonitrile, reduced and alkylated
using 10 mM dithiothreitol and 100 mM iodoacetamide and incubated with 75 ng sequencing
grade modified porcine trypsin (Promega) in 25 mM ABC overnight at 37o C. Digested samples
were spotted onto a MALDI target with ZipTipµ-C18 (Millipore Corp., MA) and eluted with
70% acetonitrile, 0.2% formic acid and overlaid with 0.5 μL of 5 mg/ml MALDI matrix (αCyano-4 hydroxycinnamic acid 10 mM ammonium phosphate). All mass spectrometric data
were collected using an ABI 4700 Proteomics Analyzer MALDI TOF/TOF mass spectrometer
(Applied Biosystems, CA), using their 4000 Series Explorer software v. 3.6. The peptide masses
were acquired in reflectron positive mode (1-keV accelerating voltage) from a mass range of 650
– 4000 Daltons, 1250 laser shots were averaged for each mass spectrum. Each sample was
internally calibrated on trypsin’s autolysis peaks 842.51 and 2211.10 to within 20ppm. Any
sample failing to internally calibrate was analyzed under default plate calibration conditions of
150ppm. Raw spectrum filtering/peak detection settings were S/N threshold of 3, and cluster area
S/N optimization enabled at S/N threshold 10, baseline subtraction enabled at peak width 50. The
twenty most intense ions from the MS analysis, which were not on the exclusion list, were
subjected to MS/MS. The MS/MS exclusion list included known trypsin masses: 842.51, 870.54,
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1045.56, 1126.56, 1420.72, 1531.84, 1940.94, 2003.07, 2211.10, 2225.12, 2239.14, 2283.18,
2299.18, 2678.38, 2807.31, 2914.51, 3094.62, 3337.76, and 3353.75. For MS/MS analysis the
mass range was 70 to precursor ion with a precursor window resolution of -1 to +4 Da with an
average 2500 laser shots for each spectrum, CID ON, metastable suppressor ON. Raw spectrum
filtering/peak detection settings were S/N threshold of 5, and cluster area S/N optimization
enabled at S/N threshold 6, baseline subtraction enabled at peak width 50. The data was then
stored in an Oracle database (Oracle database schema v. 3.19.0 Data version 3.90.0).
MALDI data analysis
The data was extracted from the Oracle database and a peak list was created by GPS Explorer
software v 3.6 (Applied Biosystems) from the raw data generated from the ABI 4700. Analyses
were performed as combination of MS + MS/MS. MS peak filtering included mass range 6504000 Da, minimum S/N filter 10. A peak density filter of 50 peaks per 200 Da with a maximum
number of peaks set to 65. MSMS peak filtering included mass range of 60 Da to 20 Da below
each precursor mass. Minimum S/N filters 10, peak density filter of 50 peaks per 200 Da, cluster
area filter used with maximum number of peaks 65. The filtered data were searched by Mascot v
2.2.04 (Matrix Science) using NCBI nr database (NCBI 2009), containing 8,080,522 sequences.
Searches were performed without restriction to protein species, Mr, or pI and with variable
oxidation of methionine residues and carbamidomethylation of cysteines. Maximum missed
cleavage was set to 1 and limited to Trypsin cleavage sites. Precursor mass tolerance and
fragment mass tolerance were set to 20 ppm and ± 0.2 Da, respectively. These files were then
analyzed using Proteome Software’s Scaffold software.
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RNA preparation
Spirochetes grown to late log phase (approximately 108 cell/ml) in 40 ml of BSK-H medium at
33°C were harvested by centrifugation. Total RNA was extracted using RNA Isolation Kit
following the manufacturer’s instruction & (Qiagen). Genomic DNA was removed through
DNase I digestion. The rRNAs were depleted using Microb Express Kit (Ambion). The RNA
concentration was determined by using ND-1000 (Nano Drop Technologies).
Real time RT-PCR
The real time RT-PCR was performed using SYBR green PCR Kit and following its instructions.
After extracting RNA from borrelia culture, cDNA from total RNA was synthesized using, 2 µg
RNA and oligo-dT for reverse transcription reaction. The DNA-free RNA preparation was first
annealed with oligo-dT (In-vitrogen) at 42˚C for 2 min, in presence of reverse transcription (RT)
buffer (In-vitrogen). Deoxynucleoside triphosphates and SuperScript II Rnase H- reverse
transcriptase was added, RT was conducted at 42˚C for 1 h, and then reaction was terminated by
heat inactivation of enzyme at 70˚C for 15 min according to manufacturer's instructions. The
cDNA preparation was diluted with nuclease free water and aliquoted into small tubes and stored
at -80˚C until further use.
Using the real time PCR primers (Table 3.1) and iTaq™ SYBR® Green Supermix with ROX
(Bio-Rad, Hercules, CA), real time PCR was performed on Applied Biosystems GeneAmp PCR
System 7900. The primers were designed to amplify sequences ranging from100-200 bps. The
absolute and relative quantitation of target RNA was calculated by comparing result data of
samples with standard curve of target and reference gene. The borrelia flaB gene was used as the
reference gene. All cDNA amplification reactions were carried out in 20µl volume in a 96-well
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PCR plate, each sample was run in triplicate. Amplification was achieved with following
parameters: 95˚C for 10 min, and 40 cycles of 95˚C for 15 s and 60˚C for 1 min. The mean
cDNA copy numbers of each sample, transcripts of each cDNA pool were automatically
calculated from triplicate wells using SDS 1.4 software. Gene expression levels were presented
as mRNA copy number per 103 flaB mRNA transcripts.
Protein extraction and SDS polyacrylamide gel electrophoresis (SDS-PAGE)
For one dimensional SDS-PAGE, cell pellets were suspended in HN buffer containing protease
inhibitor cocktail (Roche), sonicated with a Branson Digital Sonifier for 4 cycles each of 15 sec
burst followed by 1 min rest. After centrifugation at 10,000xg, supernatants were analyzed by
electrophoresis according to Laemli method using 12% TGX gel (BioRad) in Tris-glycine buffer
system for 2h at 80 volts. Gels were then stained with Bio-Safe Coomassie G-250 stain for
visualization of protein bands.
Immunoblot Analysis
The protein bands in SDS-PAGE gel were electrotransferred onto a nitrocellulose membrane
(Thermo Scientific, Rockford, IL). Different borrelial proteins (Figure 3.4 &3.5) were probed
with either a mixture or individual Monoclonal Antibodies (MAbs). The α-FlaB, were used as
positive control and used at 1:100 dilution (Barbour et al. 1986). The α-OspC, α-DbpA, α-RpoS,
and α-BosR MAbs were used in 1:10000 dilution. The α-OspC were developed by Mbow et al.
in 1999 (Mbow, Gilmore, and Titus 1999). The α-RpoS was kindly provided by F. Yang (Indiana
University School of Medicine) and the α-BosR MAbs were provided by Xin Li (Department of
Veterinary Biosciences, The Ohio State University).
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The secondary antibody used was the commercially available goat anti-mouse IgG conjugated
with horseradish peroxidase (hrp) at 1:5000 final dilution (ThermoScientific, Waltham, MA).
The commerically available Coloroimetric blotting substrate (4CN) was used to develop
nitrocellulose membrane (Kirkegaard and Perry Laboratories, Gaithesburg, MD).
Table 3.1. Primers used in the study: All the primers designed for qPCR covered 100-200 bps of
the respective genes.
Primer

Sequences (5’ to 3’)

flaBqf

CATATCTTGGAGACAGACGTAGACTTATACACGG qPCR

flaBqr

CTGCATTCCAAGCTCTTCAGCTGTTC

qPCR

ospDf1

AGGCAAATAAAGTTGTAGAAGCGGT

qPCR

ospDr2

TTCTGCCATTTGAGCTAAATCATGC

qPCR

bbj41f

AACCGAAGAATAGCTGGTCAA

qPCR

bbj41r

TTGTAGCAACTTTTCGGCTTCT

qPCR

ospDf2

GAA GGC GCA AAT TCA AAT TAC GAA TC

lp38 identification

ospDr2

CAG CAG AAT CAG AAT AGT CAG ATT C

lp38 identification

Purpose

Selection of B. burgdorferi with lost lp38 (ospA/lp38-)
The ospA knockout mutant was cultivated to late logphase in 10 ml BSK-H media at 33ºC,
pelleted by centrifugation and resuspended after washing with media. The pellet was
resuspended in 50 ml of fresh media and aliquoted for obtaining single borrelial colonies. All the
resultant clones were screened by PCR for presence of lp38 using primers as shown in table 3.1.
The PCR conditions included: 94 °C for 1 min; 94 °C for 64 seconds, 54 °C for 30 seconds, 72
°C for 1 min, 35 cycles; 72 °C for 10 min. PCR products were separated on an ethidium
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bromide-agarose gel. The selected clones were first surveyed for the presence of lp28-1 because
this plasmid is essential for persistent infection of immunocompetent hosts (Fingerle et al. 2007,
Crother et al. 2004, Barbour et al. 1986). Only clones containing lp28-1 were further analyzed
for Osp expression study.
In-vitro characterization of selected clones
The selected ospA mutants lacking lp38 were grown in Barbour-Stoenner-Kelly H (BSK-H)
complete medium (Sigma Chemical Co., St. Louis, MO) to late-log phase at 33oC, and harvested
by centrifugation. Spirochete lysates were subjected to immunoblot analysis probed with FlaB
(Raetz and Whitfield 2002), OspA (Xu, McShan, and Liang 2007) or OspC mAb (Xu, McShan,
and Liang 2007). Immunoblotting was performed as described (Sears et al. 1991).
Microscope image
The wild type B. burgdorferi 13A, ospA mutant (ΔospA), both strains with and without lp38
(ΔospA/lp38+ & ΔospA/lp38-) and the ospA complement (ΔospA/ospA) spirochetes were grown
to early log phase (107 cells/ml) in BSK-H medium at 33°C and harvested by centrifugation from
1.0 ml culture. The harvested spirochetes were resuspended in 20µl PBS and then charged onto
fresh glow-discharged holey carbon grids for 1 min. A filter paper was used to blott the Grids
were and then rapidly frozen in liquid ethane, using a homemade gravity-driven plunger
apparatus. Polara G2 electron microscope, with field emission gun and a 16 megapixel camera,
operated at 300 kV was used for imaging the frozen-hydrated samples at -170°C (FEI Co.,
Hillsboro, OR).
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Statistical analysis
The qPCR data was analyzed using a one-way analysis of variance (ANOVA), followed by a
two-tailed Student t test to compare both conditions and calculate P values of ≤ 0.05 were
considered to be significant. Fisher’s exact test was used to analyze tissue colonization data.
GraphPad Prism 5.0 was used for calculations (GraphPad Software Inc., La Jolla, CA)
Results
Deletion of the ospA locus leads to dramatic up-regulation of OspD and BBJ41 and
complementation reduces their expression to an undetectable level
The protein analysis of an ospA mutant showed two protein bands that were substantially upregulated (Figure 3.1). Complementation of the mutant with the ospA gene alone repressed the
two polypeptides to an undetectable level. As OspA are such highly expressed Osps, not
regulators, when B. burgdorferi is grown in vitro, these observations led us to hypothesize in
previous study that the outer surface lipoprotein layer is required for basic survival of the
spirochete and its homeostasis is an overwhelming force to gene regulation (Xu, McShan, and
Liang 2008). Based on the previous study we hypothesised that the two highly upregulated
protein bands as shown in figure 3.1 may be that of some other outer surface lipoproteins that
might have been up-regulated in ospA mutant to compensate for the loss of OspAB and
maintainence of the outer surface lipoprotein layer homeostasis.

81

Figure3.1. Disruption of the ospA locus leads to dramatic upregulation of OspD and BBJ41, and
complementation with ospA causes their downregulation to an undetectable level. The two
greatly upregualated protein bands were initially unidentified. Proteins were further purified by
using 2-D gel electrophoresis, and identified as outer surface lipoproteins OspD and BBJ41by
MS-Spect analysis.

Identification of two highly upregulated proteins as OspD & BBJ41 in ospA knockout
(∆ospA):
The two highly upregulated polypeptides were separated using 1-D (Figure 3.1) and 2-D gel
electrophoresis (Figure3.2).

Purified protein Spots or bands were excised with robot and

analyzed by MS-Spect. The MS-Spect analysis identified the two highly upregulated proteins to
be 28kDa OspD (spot 1’/1, 2’/2, and 3’/3) and 35kDa BBJ41 (spot 5’/5) both expressed as outer
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surface lipoproteins in B. burgdorferi. Additionally, OspD and BBJ41 were also identified on 1D gel directly using same method (Figure 3.1).

Figure 3.2. The 2-D gel electrophoresis for wild type B. burgdorferi 13A & OspA knock out.(A)
2-D gel image for wild type strain 13 A of Borrelia burgdorferi.(B)2-D gel image for ospA
mutant. MS-Spec analysis revealed Spots 1’/1, 2’/2, and 3’/3 as OspD; Spot 4’/4 as GAPDH.
Spot 5’/5 as BBJ41; Spot 6’/6, 7’/7, 8’/8 as FlaB & Spot 9’ as OspA.
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Over expression of identified protein at mRNA level
The dramatic regulation of OspD and BBJ41 was further confirmed at the mRNA level. RNA
was extracted from the parental strain 13A, ∆ospA and ∆ospA/ospA and analyzed by qRT-PCR.
As shown in figure 3.3, the expression level changed 16 and 21 times for ospD and bbj41,
respectively. These results clearly show that expression of OspD and BBJ41 is highly increased
at the mRNA level in absence of ospA, thus indicating that absence of OspA is compensated by
upregulation of OspD and BBJ41.

Figure 3.3. Absence of ospA causes increased expression of Outer surface lipoproteins, OspD &
BBJ41 at mRNA level: (A) qRTPCR results for ospD show 16 fold rise in mRNA copy and (B)
qRTPCR results for bbj41 show 21 fold rise in mRNA copy in comparison to the wild type 13A
strain of B. burgdorferi.
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Deprivation of lp38, the plasmid that carries the ospD and bbj41 genes, leads to constitutive
expression of RpoS and its dependent Osps
In order to continue to address the hypothesis that homeostasis of the Osp layer overrides the
normal regulatory program, we initially attempted to inactivate both ospD and bbj41 genes. As
the plasmid lp38, which carries both the genes, is not essential for infection and may be easily
lost, we designed experiments to isolate clones that lose the plasmid. A total of 56 clones were
selected; only one of them, namely ΔospA/lp38-, had lost lp38. The 13A, ΔospA, and ΔospA
(lp38-) spirochetes were grown to early log phase, harvested, analyzed by SDS-PAGE, and
stained with Coomassie staining (Figure3.4A) and probed by immunoblotting with α-FlaB & αOspC (Figure 3.4 B & C). The protein analysis below clearly show that OspC is induced in ospA
mutant lacking lp38, these results indicate that OspC is upregulated in response to an absence of
OspA, OspD & BBJ41. As OspC expression is induced by RpoS, we further analysed ospA
mutant without lp38 for presence of other RpoS induced Osps. Hence immunoblotting with αDbpA was done (Figure3.4D). Taken together these results indicate that absence of major Osps
caused induction of RpoS and hence the RpoS regulated Osps, OspC & DbpA, thus maintaining
the surface homeostasis and overriding usual regulatory mechanisms and ensuring the survival of
B. burgdorferi.
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Figure 3.4. Depletion of lp38, the plasmid that carries both ospD and bbj41 genes, leads to
constitutive RpoS activation as well as dramatic upregulation of RpoS-dependent osps. The
ΔospA culture was subcloned through a serial dilution. A total of 56 clones were selected; only
one of them, namely ΔospA (lp38-), lost lp38. The 13A, ΔospA, and ΔospA (lp38-) spirochetes
were grown to early log phase, harvested, analyzed by SDS-PAGE, and stained with Coomassie
staining (A) and immunoblotting probed with (B) flaB, (C) RpoS, and (D) DbpA antibodies.
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Complementation of ΔospA (lp38-) with ospA represses constitutive expression of RpoS and
its dependent osps
RpoS is continuosly expressed throughout the mammalian phase of Lyme disease, it regulates
many important mammalian phase Osps, including OspC, DbpA/B and BBK32. The
experimental results above show that RpoS is induced in vitro in the absence of major tick phase
Osps like OspA & OspD. To ensure that RpoS was induced in a compensatory response to the
absence of major Osps like OspA, we complemented ospA mutant lacking lp38 with ospA
plasmid. Complementation of ospA mutant resulted in reduced expression of RpoS upregulator
BosR, hence RpoS and OspC (Figure 3.5). These results clearly indicate that RpoS was induced
in ospA mutant lacking lp38 as the osp layer homeostatic response in B.burgdorferi.

Figure 3.5. Complementation of ospA mutant represses BosR which represses RpoS and hence
the RpoS induced OspC. (A) Coomassie stained SDS-PAGE showing clear reversal of
compensatory OspC expression on complementation of ospA mutant with pBBE22-ospA. (B)
Immunoblot probing with α-FlaB, α-OspC, α-RpoS, and α–BosR antibodies indicate significant
reduction in BosR, RpoS, and OspC expression upon complementation of ospA mutant with
ospA.
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Homeostasis of the Osp layer
The advanced technology of cryo-electron microscopy allowed the observation of the density of
the outer surface lipoprotein layer directly under cro-te. (Figure 3.6). The microscopic images
clearly show that the density of osp layer did not change under distinct conditions with regard to
the different dominant osps. All the B. burgdorferi strains including wild type 13A, ospA mutant
lacking lp38 (consequently lacking OspD, BBJ41 & OspA) and ospA mutant retaining lp38 show
similar density of osp layer (Figure 3.6). The same results are supported by the above
experimental results which showed that the ospA mutant lacking lp38 induces RpoS and hence
RpoS regulated osps like OspC & DbpA. This enables ospA mutant to retain contant osp layer
density. Similarly in the ospA mutant with lp38, the overexpression of OspD and BBJ41
compensates for the loss of OspA and the density of the osp layer remains unchanged even in the
absence of dominant ospA locus.

Figure 3.6. The overall density of the osp layer remains unchanged irrespective of the expression
levels of each individual osp. The 13A, ΔospA and ΔospA/ospA spirochetes were grown to early
log phase and imaged using the Polara G2 electron microscope. Images A & E show osp layer
for wild type B. burgdorferi 13A, Images B & F show osp layer for ΔospA lacking ospD
containing lp38, Images C and G show osp layer for ΔospA/ospA, and Images D and H shows
proteinase treated wild type B. burgdorferi completely lacking the osp layer.
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All these results taken together indicate that the osp layer in B. burgdorferi exists in a state of
homeostasis. The regulation of this homeostasis takes priority over the normal osp expression
and loss of one osp is compensated by expression of another osp.

Discussion
One feature of the Lyme disease spirochete, Borrelia burgdorferi, is to abundantly express outer
surface lipoproteins (osps) and to form a lipoprotein layer to coat itself (Beck et al. 1985, Radolf
et al. 1994). It has been known for years that the spirochete constantly modifies the component
of the antigen layer to adapt to diverse environments and evade the immune system (Schwan
2003, Gutierrez Fernandez et al. 1997, Barbour 1991, Koomey 1997). A previous study has
shown that maintenance of surface lipoprotein coat is central to survival of spirochete (Xu,
McShan, and Liang 2008). However, the knowledge of interplay amongst several Outer surface
lipoproteins is still incomplete and is a matter of investigation in borrelia research.
OspA is the most dominantly expressed osp when B. burgdorferi resides in tick and is grown invitro. During the generation of the ospA mutants in a previous stuy, it was noticed that,
inactivation of ospA gene was more difficult than any other osp genes. Furthermore, it was
observed that the ospA mutants grow unhealthily in vitro (Barbour et al. 1986). One explanation
to these observations during the generation of ospA mutant can be that absence of OspA would
cause a dramatic reduction in the density of the osp layer and hence ospA mutants that are not
able to upregulate other osps in compensation of OspA fail to thrive well. Hence, deletion of
ospA is lethal if the spirochetes do not increase the expression of other osps to compensate for
the loss (Barbour et al. 1986).
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The current study reconfirmed that the integrity of the lipoprotein layer is crucial for the basic
survival of B. burgdorferi and that the requirement for maintaining this integrity is above the
normal regulatory programs. The deletion of the ospA locus, which encodes the two most
abundantly expressed osps when B. burgdorferi is grown in vitro or inhabits the tick vector
(Howe, Mayer, and Barbour 1985, Beck et al. 1985), led to dramatic increase in expression of
two other osps, namely OspD and BBJ41. Hence it can be stated that osps compensate for each
other in order to maintain constant surface lipoprotein coat.
This was further corroborated as the complementation with the ospA gene alone completely
repressed the two highly upregulated osps to an undetectable level and depletion of lp38, the
plasmid that carries both ospD and bbj41, resulted in a constitutive expression of RpoS and its
dependent osps like OspC. In addition to the above observations, the complementation of the
lp38-deficient ospA mutant with ospA led to a significant repression of the constitutively
expressed RpoS and its dependent osps.
Finally, the hypothesis regarding constant homeostatic maintenance of surface lipoprotein coat
was confirmed by cryo-electron microscopy, which showed that the density of the osp layer
remains constant regardless of expression levels of individual osps. Taken together, the study
demonstrated that outer surface lipoprotein layer homeostasis overwhelms regulatory programs
in B. burgdorferi. This theory should help in interpretation of many experimental results, such as
inactivation of a major osp would lead to great upregulation of other ones. The understanding of
interplay amongst different osps in biology of B. burgdorferi, may lead to new approaches for
prevention and treatment of enigmatic Lyme disease.
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CHAPTER 4
GENERAL CONCLUSIONS AND DISCUSSION
Lyme disease is currently the most commonly reported vector borne disease in the United States
(Bacon et al. 2008). The causative agent of Lyme disease B. burgdorferi sensu stricto, is mainly
responsible for the disease in North America. In its North American cycle, B. burgdorferi
mostly gets transmitted amongst small mammals (Levine, Wilson, and Spielman 1985).
However, the Lyme disease transmission to humans is accidental and they act as the dead-end
host. The bite of infected Ixodes scapularis on the east coast (and mid central) and Ixodes
pacificus on the west coast (Anderson 1989, Anderson and Magnarelli 1980, Barbour 1998) acts
as the main mode of transmission of Lyme disease.
The need of rapid adaptation to the discrete invertebrate and mammalian environments elicit
impressive genetic manipulation by B. burgdorferi. The small genome of B. burgdorferi is
coordinated by an intricate molecular mechanism still incompletely known and understanding
the molecular mechanism of borrelial adaptation may lead to identification of suitable targets for
development of effective Lyme disease prevention strategies.
In order to adapt and survive in the disparate environments B. burgdorferi has to differentially
regulate its whole transcriptome, this global adjustment is accomplished through the use of RNA
polymerase sigma factors. The genome of B. burgdorferi encodes only three sigma factors, the
constitutive sigma factor RpoD (σ70), and two alternate sigma factors, RpoN (σ54) and RpoS (σS)
(Fraser et al. 1997). The alternate sigma factors form a well-coordinated cascade where rpoS
depends on RpoN for its transcription, which in turn relies on Rrp2 a phosphorylation activated
protein (Yang, Alani, and Norgard 2003, Smith et al. 2007).
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BosR is a recent addition to the key regulatory molecules known for the regulation of RpoNRpoS pathway. Other than bosR itself, rpoS and napA/bicA are the only two other known genes
that are directly activated by BosR (Ouyang et al. 2009, Wang et al. 2012). The previous studies
have shown that the downregulation of OspA is mediated indirectly through RpoS via a DNA
binding repressor molecule (Caimano et al. 2005). The present study shows that BosR can
directly bind to the upstream regulatory sequences of ospA and ospD genes. It also proves that
BosR causes direct repression of OspA by binding to cisI and cisII regulatory elements (Xu,
McShan, and Liang 2010). Thus, this study provide sufficient evidence to support the hypothesis,
that OspA downregulation is not essentially RpoS dependent and BosR acts as a direct repressor
for OspA.
Furthermore, the present study also indicates that BosR mediates complete shut off of OspA
only when the constitutive expression of other surface lipoproteins (OspC, DbpA and DbpB) is
provided. This can be explained by the putative homeostasis existing on the outer surface
membrane of B. burgdorferi.

The surface lipoproteins play a protective role and hence

downregulation of a major surface lipoprotein like OspA may not be complete till borrelia has
other Osps to compensate (Yang et al. 2004, Xu, McShan, and Liang 2008). Even in the natural
infectious cycle OspA downregulation is not 100%. As B. burgdorferi prepares to infect the
mammalian host, downregulation of OspA occurs only in about 50% of the total spirochete
population colonizing the tick midgut before migration to the tick salivary glands (Ohnishi,
Piesman, and de Silva 2001). Hence OspA shutoff is difficult for B. burgdorferi even in nature.
Most of the differentially regulated genes in borrelia that participate in the adaptive response to
an external environmental change, encode for one or the other outer surface lipoprotein. Being an
interface between external and internal environment, outer surface lipoproteins play a central
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role in survival adaptations of B. burgdorferi (Xu, McShan, and Liang 2008). Furthermore, there
have been several studies which have pointed the homeostatic balance in osp expression on the
outer membrane of B. burgdorferi. One such study showed that the deletion of the ospA operon
caused constitutive activation of the Rrp2-RpoN-RpoS pathway and hence osps controlled by it
like OspC, DbpA and DbpB (He et al. 2008). In another such study, the ospA mutant appeared to
have increased expression of several outer surface lipoproteins, but none of these were RpoS
regulated (Battisti et al. 2008). Similarly, an ospC mutant showed upregulation of several other
lipoproteins regulated by the RpoS regulon (Pal et al. 2004). The present study proves the
existence of osp layer homeostasis and presents two new osps, OspD and BBJ41, wich
compensate for the absence of dominat OspA and maintain outer surface homeostasis.
Many putative lipoproteins encoded by B. burgdorferi have been implicated in corroborating tick
vector colonization and disease transmission, however, precise mechanisms and function of most
of these remains largely unknown. The present study adds to knowledge of osp regulation as it
shows how BosR acts a repressor for OspA.
In the natural infectious cycle the downregulation of OspA on surface is compensated by
upregulation of OspC as B. burgdorferi prepares to infect the host. This crossregulation of OspAOspC has been demonstrated as a key factor for causing infection in mammalian host. Further in
its infection phase, borrelia downregulates even OspC and replaces it by VlsE outer surface
protein. Thus, broadly, Osps of borrelia protect it from mammalian immune system, enable its
successful persistence in tick vector and ensures continuation of the natural infection cycle (Xu,
McShan, and Liang 2008).
Exact regulatory mechanisms involved in controlling the osp expression are complex and still
largely unknown. However, OspA is one such significant osp which forms a dominant
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expression on the surface while B. burgdorferi lies dormant in an unfed tick midgut, it is rapidly
downregulated in response to blood meal from an uninfected mammalian host. The rapid
downregulation of OspA is important to protect borrelia from mammalian immune system as the
antibodies against OspA once produced can eliminate B.burgdorferi from it enzootic cycle.
Therefore, OspA has been an attractive target for development of vaccine against Lyme disease
and, also a vaccine using an immunogenic recombinant B. burgdorferi outer surface protein
(OspA) was licensed by the US Food and Drug Administration (FDA). Unfortunately, vaccine
was withdrawn citing multiple concerns. Understanding the differential regulation of ospA may
lead us for identification of additional target for disruption of the homeostasis of outer surface
proteins required for the survival of borrelia in different host environment. The present study
deals specifically with questions pertaining to downregulation of OspA and what happens on
borrelial surface in its absence.
While the incidence of Lyme disease continues to increase along with its expanding endemic
area, the ambiguous clinical manifestations still pose a challenge to early diagnosis of Lyme
disease. Though antibiotic therapy is currently available for treating Lyme disease in early
stages, it is still not successful in treating antibiotic refractory Lyme arthritis and post lyme
disease syndrome (chronic lyme disease). Hence the current tools for prevention, diagnose, and
treatment of Lyme disease are limited.
The main goal for the studies described in this dissertation is to delve further into the molecular
mechanisms of differential gene regulation and function of outer surface lipoprotein in the
infectious life cycle of B. burgdorferi. One part of this study adds to such observations where the
absence of OspA in an ospA deficient B. burgdorferi is compensated by increased OspD and
BBJ41 expression. Both these tick phase surface lipoproteins are not expressed in mammalian

97

host and need to be investigated for their potential as vaccine targets. The electron microscopy
results clearly show maintenance of constant lipoprotein density on the outer membrane layer in
B. burgdorferi irrespective of the osp gene mutation. This study for the first time clarifies well
speculated homeostatic osp maintenance on the borrelial surface, which is critical for
development of intervention strategies for the Lyme disease. Our study has re-emphasized the
need for further investigations into the alternative mechanisms of downregulation of OspA,
independent to RpoS.
Understanding the gene regulation and outer surface lipoprotein layer functioning can potentially
provide important targets for interrupting B. burgdorferi infectious cycle and development of
vaccine against Lyme disese.
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